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Genes in Duplication 15q Syndrome
Abstract
Duplication 15q syndrome (Dup15q) is a genetic disorder caused by duplications of the 15q11.2-q13.1
region and is characterized by developmental delay, autism spectrum disorder, and treatment resistant
epilepsy. Extra copies of the E3 ubiquitin ligase UBE3A and elevated levels of UBE3A expression in
neurons are thought to be the primary cause of Dup15q phenotypes. However, animal models
overexpressing UBE3A in neurons have not successfully recapitulated all aspects of Dup15q syndrome,
especially epilepsy. Here, we used Drosophila melanogaster (fruit flies) to investigate Dup15q syndrome.
In Chapter 2 we explored whether Dube3a, the Drosophila homolog of UBE3A, is imprinted in the fly brain.
In mammals, UBE3A undergoes complex imprinting and is expressed only from the maternal allele in
mature neurons. Prior to this work the imprinting status of Dube3a in flies was unclear. Here, we present
evidence that Dube3a is not imprinted and is biallelically expressed in the fly. Next, in Chapter 3 we
examined the interaction between Dube3a and HERC2. HERC2 is also an E3 ubiquitin ligase located in the
15q11.2-q13.1 critical region and is duplicated in all Dup15q individuals. HERC2 physically interacts with
and stimulates the ubiquitin ligase activity of UBE3A in vitro. We found that Drosophila HERC2 appears to
stimulate the ubiquitin ligase function of Dube3a, and Dube3a and HERC2 interact synergistically to
impact phenotypes associated with Dup15q syndrome in vivo. Data presented in Chapter 3 suggests that
genes other than UBE3A are important in generating the Dup15q phenotypes and should not be ignored
when modeling Dup15q syndrome. In Chapter 4 we investigated how non-neuronal cells, specifically glial
cells, contribute to the seizure phenotype of Dup15q syndrome. We found that elevated levels of Dube3a
or UBE3A in glia causes seizures, while overexpression in neurons does not. These data are consistent
with mammalian models in which UBE3A elevation in neurons does not generate seizures. Furthermore,
overexpression of Dube3a in glia reduced protein levels of the Na+/K+ ATPase, ATPα. ATPα down
regulation in glia is both necessary and sufficient to generate seizures. In Chapter 5 we further
characterized our Dup15q epilepsy model and investigated cell type specific effects of Dube3a
overexpression in glia compared to neurons using whole transcriptome and whole proteome analyses. We
found that elevation of Dube3a in glia caused a cell non-autonomous down regulation of synaptic
proteins in neurons while simultaneously causing a cell autonomous upregulation of glutathione Stransferases (GSTs) in glial cells. Finally, we showed that the upregulation of GSTs is common to multiple
different Drosophila gliopathic seizure lines, not just our Dup15q epilepsy model. GSTs play a role in drug
metabolism, and elevation of these enzymes may underlie the treatment resistant nature of some
epilepsies including Dup15q syndrome. The results from these studies highlight the role that glial cell
dysfunction may play in generating seizures in Dup15q syndrome and could ultimately provide novel
avenues for epilepsy treatments.
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ABSTRACT
Duplication 15q syndrome (Dup15q) is a genetic disorder caused by duplications
of the 15q11.2-q13.1 region and is characterized by developmental delay, autism
spectrum disorder, and treatment resistant epilepsy. Extra copies of the E3 ubiquitin
ligase UBE3A and elevated levels of UBE3A expression in neurons are thought to be the
primary cause of Dup15q phenotypes. However, animal models overexpressing UBE3A
in neurons have not successfully recapitulated all aspects of Dup15q syndrome,
especially epilepsy. Here, we used Drosophila melanogaster (fruit flies) to investigate
Dup15q syndrome. In Chapter 2 we explored whether Dube3a, the Drosophila homolog
of UBE3A, is imprinted in the fly brain. In mammals, UBE3A undergoes complex
imprinting and is expressed only from the maternal allele in mature neurons. Prior to this
work the imprinting status of Dube3a in flies was unclear. Here, we present evidence that
Dube3a is not imprinted and is biallelically expressed in the fly. Next, in Chapter 3 we
examined the interaction between Dube3a and HERC2. HERC2 is also an E3 ubiquitin
ligase located in the 15q11.2-q13.1 critical region and is duplicated in all Dup15q
individuals. HERC2 physically interacts with and stimulates the ubiquitin ligase activity
of UBE3A in vitro. We found that Drosophila HERC2 appears to stimulate the ubiquitin
ligase function of Dube3a, and Dube3a and HERC2 interact synergistically to impact
phenotypes associated with Dup15q syndrome in vivo. Data presented in Chapter 3
suggests that genes other than UBE3A are important in generating the Dup15q
phenotypes and should not be ignored when modeling Dup15q syndrome. In Chapter 4
we investigated how non-neuronal cells, specifically glial cells, contribute to the seizure
phenotype of Dup15q syndrome. We found that elevated levels of Dube3a or UBE3A in
glia causes seizures, while overexpression in neurons does not. These data are consistent
with mammalian models in which UBE3A elevation in neurons does not generate
seizures. Furthermore, overexpression of Dube3a in glia reduced protein levels of the
Na+/K+ ATPase, ATPα. ATPα downregulation in glia is both necessary and sufficient to
generate seizures. In Chapter 5 we further characterized our Dup15q epilepsy model and
investigated cell type specific effects of Dube3a overexpression in glia compared to
neurons using whole transcriptome and whole proteome analyses. We found that
elevation of Dube3a in glia caused a cell non-autonomous downregulation of synaptic
proteins in neurons while simultaneously causing a cell autonomous upregulation of
glutathione S-transferases (GSTs) in glial cells. Finally, we showed that the upregulation
of GSTs is common to multiple different Drosophila gliopathic seizure lines, not just our
Dup15q epilepsy model. GSTs play a role in drug metabolism, and elevation of these
enzymes may underlie the treatment resistant nature of some epilepsies including Dup15q
syndrome. The results from these studies highlight the role that glial cell dysfunction may
play in generating seizures in Dup15q syndrome and could ultimately provide novel
avenues for epilepsy treatments.
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CHAPTER 1.

INTRODUCTION

Duplication 15q Syndrome: Diagnosis and Subtypes
The first cases of Duplication 15q syndrome (Dup15q) were reported in the early
1990’s. A young girl who presented clinically with delayed language development, ataxic
gait, and global developmental delay was found to carry extra genetic material located on
the q arm of her maternally inherited chromosome 15 (Clayton-Smith, Webb et al. 1993).
At the same time a second group characterized a cohort of individuals carrying extra
genetic material on chromosome 15q, and based on the inverted nature of the
chromosomal duplication the chromosomal abnormality was termed inv dup(15)
(Robinson, Binkert et al. 1993), which is now broadly recognized as Dup15q syndrome.
Following these initial studies, the specific region of chromosome 15q that is
duplicated has been identified. Dup15q is now known to be caused by the presence of at
least one extra copy of the Prader Willi/Angelman critical region (PWACR) located
within the 15q11.2-q13.1 region (Finucane, Lusk et al. 2016). Estimates of Dup15q
prevalence rates vary. In individuals referred for clinical genetic testing by chromosomal
microarrays due to hypotonia, motor delays, speech delays, autism spectrum disorder
(ASD), or seizures, 15q11.2-q13.1 copy number gains are detected at a frequency of 1 in
508 (Moreno-De-Luca, Sanders et al. 2013). Multiple subtypes exist so further testing is
required to identify the exact subtype of Dup15q. Fluorescent in situ hybridization
(FISH) or cytogenetic analysis can determine whether a duplication resides within
chromosome 15, termed interstitial Dup15q, or whether there is a supernumerary
chromosome, termed isodicentric Dup15q. Parent of origin testing is useful in cases of
interstitial Dup15q, however isodicentric Dup15q appears to be only maternally derived
and evidence for familial inheritance has not been reported. In cases of interstitial
Dup15q, further genetic testing can reveal whether the duplication event was inherited
maternally or paternally. Paternally inherited interstitial Dup15q presents with a less
severe phenotype and set of symptoms different from maternally derived duplications.
Maternal interstitial Dup15q can be inherited familially if the mother carries a paternally
derived interstitial duplication within her genome, so identifying parent of origin is
important to determine if other relatives are at risk. See Figure 1-1 for a diagram of
Dup15q subtypes.
Dup15q syndrome results in a number of disease phenotypes and both the
presence and severity of these phenotypes differs among the Dup15q subtypes, and even
among individuals with the same genetic subtype. The phenotypes discussed in the
following sections apply primarily to maternally derived duplications. Paternal interstitial
Dup15q phenotypes will be discussed in a section on related genetic disorders.
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Figure 1-1. Chromosome diagram of Dup15q subtypes.
Typical individuals carry one 15q11.2-q13.1 region (yellow) on the paternal chromosome
(blue) and one on the maternal chromosome (red). In cases of maternal isodicentric
chromosome 15, a supernumerary chromosome is present that contains two extra copies
of 15q11.2-q13.1. Maternal and paternal interstitial duplications can also occur creating
one extra copy of the 15q11.2-q13.1 region within the chromosome. Additionally,
paternal triplication cases can occur carrying two extra paternally derived copies of
15q11.2-q13.1. In this figure, UBE3A is illustrated to be expressed only from the
maternal chromosome, which occurs in neurons. In non-neuronal cell types, UBE3A is
expressed from both the maternal and paternal copies.
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The Phenotypic Consequences of 15q11.2-q13 Duplications
Autism Spectrum Disorder (ASD)
According to the DSM-V, ASD is defined by two core components. The first is
impairments in social communication and social interaction across a broad range of
contexts, which includes deficits in social-emotional reciprocity, nonverbal
communication, and maintaining and understanding relationships. The second component
is repetitive and restrictive behaviors consisting of repetitive movements, behavioral
inflexibility, and fixated interests (American Psychiatric Association 2013). Greater than
50% of maternal interstitial duplications and greater than 80% of maternal isodicentric
duplication individuals meet ASD diagnostic criteria (Hogart, Wu et al. 2010, Urraca,
Cleary et al. 2013, Al Ageeli, Drunat et al. 2014). ASD in Dup15q shares many features
with non-syndromic idiopathic ASD, the exception being one category of the ADOS-R
test whereby responsive social smile and directed facial expressions are less impaired in
the Dup15q population than the average in idiopathic ASD individuals (DiStefano,
Gulsrud et al. 2016).
Epilepsy
Epilepsy is present at high rates in Dup15q syndrome and is one of the top
concerns for the caregivers of Dup15q individuals. Seizure prevalence and severity is
positively correlated with 15q11.2-q13.1 copy number with 25% of maternal interstitial,
64% of maternal isodicentric, and 100% of complex duplications (up to 6 extra copies)
having seizures (Conant, Finucane et al. 2014). The majority of Dup15q cases present
with multiple seizure types including tonic-clonic, atonic, myoclonic, and focal seizures,
making epilepsy difficult to treat in this syndrome. Approximately half of Dup15q
individuals with epilepsy develop treatment resistant refractory seizures (Conant,
Finucane et al. 2014), severely impacting their quality of life. The mechanism of seizure
in Dup15q remains poorly understood, and treatment options are limited.
Global Developmental Delay
Global developmental delay (DD) and impairment in fine motor skills is a feature
that distinguishes Dup15q from other forms of nonsyndromic ASD (Hogart, Wu et al.
2010, DiStefano, Gulsrud et al. 2016). Dup15q is also characterized by walking
impairments including increased stride width and a more varied gait pattern (Bhatt,
Dickinson et al. 2018). Individuals with seizures present with lower IQ scores and greater
impairments in motor function compared to Dup15q individuals without seizures
(DiStefano, Gulsrud et al. 2016), suggesting that seizures impact cognitive and motor
function beyond what is typically observed in the syndrome. However, the causal
relationship remains unclear.
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Treatment Strategies
Due to the broad nature of the disease phenotypes a multidisciplinary approach is
needed to effectively manage Dup15q syndrome. Physical therapy and augmented
communication methods can be useful to manage hypotonia and speech impairments.
Periodic seizure monitoring is recommended, as are broad spectrum antiepileptic drugs
(AEDs) to manage seizures and avoiding known seizure triggers (reviewed in Finucane,
Lusk et al. 2016). Some AEDs exacerbate seizures in the Dup15q population, making the
epilepsy aspect of Dup15q particularly difficult to manage (Conant, Finucane et al.
2014). Unfortunately, treatment strategies are designed to address features of Dup15q,
and mechanistic insights into the underlying causes of Dup15q phenotypes are needed in
order to develop more effective, targeted treatments.
The Genetic and Molecular Basis of Dup15q Syndrome
Genomic Origin of 15q Duplication
There are several complex low copy repeats (LCRs) located on chromosome 15
that significantly increase inter- and intrachromosomal duplication events in this region
(Bailey, Gu et al. 2002). The 15q11.2-q13.3 region contains 5 distinct complex LCRs,
generating 5 distinct breakpoints for most duplication and deletion events. During
meiosis I, unequal nonallelic homologous recombination can occur between these LCRs,
generating the common deletions and duplications observed in this region (reviewed in
Gu, Zhang et al. 2008). Breakpoints 2-3 within the 15q11.2-q13.1 region contain the
PWACR and this is the critical region that is duplicated in all Dup15q individuals. As
predicted by the presence of LCRs, reciprocal deletions of the 15q11.2-q13.1 region also
can occur. Depending on the parent of origin of the deletion, these events cause two
distinct neurodevelopmental disorders, Angelman syndrome (AS) or Prader-Willi
syndrome (PWS) (Hogart, Wu et al. 2010).
Genomic Imprinting Within the 15q11.2-q13.1 Locus
The Dup15q phenotype is variable depending on both copy number and the parent
of origin of the duplication. Maternally derived duplications display a more severe
phenotype than more rare paternal duplications (Cook, Lindgren et al. 1997, Schroer,
Phelan et al. 1998, Urraca, Cleary et al. 2013), suggesting that critical genes in the region
are subject to allele specific expression. Genomic imprinting refers to the process by
which DNA is epigenetically marked, in this case through DNA methylation, resulting in
differential gene expression dependent upon the parental origin of the DNA sequence.
Two imprinting centers lie within the 15q11.2-q13.1 locus. The Angelman syndrome
imprinting-center (AS-IC) is located upstream of the Prader-Willi syndrome imprintingcenter (PWS-IC) and regulates the methylation status of the PWS-IC. While the exact
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mechanism remains unclear, transcriptional activity at the AS-IC leads to DNA
methylation at the PWS-IC within oocytes (Dittrich, Buiting et al. 1996, Kelsey and Feil
2013, Lewis, Brant et al. 2015), rendering the PWS-IC methylated and silenced on the
maternally derived chromosome. The SNURF/SNRPN locus resides within the PWS-IC.
The SNURF/SNRPN transcript is only expressed from the paternal allele due to the
unmethylated status of the PWS-IC on the paternal chromosome. In mature mammalian
neurons, the SNURF/SNRPN transcript progresses into the Ubiquitin protein ligase E3A
(UBE3A) gene and becomes the UBE3A-antisense transcript (UBE3A-AS). The UBE3AAS is on the opposite DNA strand of UBE3A. Expression of UBE3A-AS sterically
interferes with expression of UBE3A on the paternal chromosome, rendering paternal
UBE3A imprinted and silenced in mature mammalian neurons (reviewed in LaSalle,
Reiter et al. 2015). In non-neuronal cell types, the SNURF/SNRPN transcript does not
progress into the UBE3A gene and both the maternal and paternal copy of UBE3A are
expressed. See Figure 1-2 for a diagram of UBE3A imprinting.
Ubiquitin Protein Ligase E3A (UBE3A)
The maternally imprinted UBE3A gene, located within the 15q11.2-q13.1 critical
region, is thought to play a primary role in the etiology of Dup15q syndrome phenotypes.
UBE3A, also known as E6 associated protein (E6AP), was originally identified as the
ubiquitin ligase that interacts directly with the human papillomavirus (HPV) E6
oncoprotein to cause the degradation of p53 during viral infection (Huibregtse, Scheffner
et al. 1993). The primary role of UBE3A as an E3 ubiquitin ligase is to build K48 linked
polyubiquitin chains on substrate proteins (Kim and Huibregtse 2009), signaling these
proteins for degradation by the 26S proteasome (Zheng and Shabek 2017). HPV-16
causes cervical cancer by introducing the E6 viral protein into a cell, resulting in
ubiquitination and degradation of the tumor suppressor p53 by UBE3A and leading to
unchecked cell growth and carcinogenesis (Scheffner, Huibregtse et al. 1993). It is
important to note that when E6 viral oncoprotein is not present, UBE3A does not target
p53 for ubiquitination.
UBE3A is the founding member of the homologous to the E6AP carboxyl
terminus (HECT) domain E3 ligase family of ubiquitin ligase proteins. The C-terminus of
UBE3A contains the active site responsible for substrate protein ubiquitination. All
HECT domain protein family members contain a region of 350 amino acids homologous
to the C-terminus of UBE3A. The C-terminus of UBE3A is responsible for interacting
with cognate E2 ligases that carry activated ubiquitin, while the N-terminus is involved in
substrate protein identification. Human UBE3A exists in at least three different isoforms
and is predicted to be expressed in both the nucleus and cytoplasm (reviewed in LaSalle,
Reiter et al. 2015). Immunohistochemistry on human brain tissue indicates that UBE3A is
present in both the nucleus and cytoplasm of neurons, including synaptic terminals and
dendrites, and is also detected in oligodendrocytes and astrocytes in human brain tissue
(Burette, Judson et al. 2018). Studies from postmortem Dup15q brain tissue (Scoles,
Urraca et al. 2011) and Dup15q patient derived dental pulp stem cell neuron cultures
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Figure 1-2. Mechanism of UBE3A imprinting.
A) In neurons, UBE3A is paternally silenced and only expressed from the maternal allele
of chromosome 15. Transcriptional activity at the maternal Angelman syndromeimprinting center (AS-IC) leads to methylation of the Prader-Willi syndrome-imprinting
center (PWS-IC) which shuts down expression of the UBE3A-AS on the maternal copy.
However, on the paternal chromosome, the PWS-IC is unmethylated and the UBE3A-AS
sterically interferes with expression of UBE3A, leading to UBE3A silencing. B) In nonneuronal cells, the SNRF/SNRPN transcript expressed from the PWS-IC on the paternal
chromosome does not progress into the UBE3A gene and, therefore, no UBE3A-AS is
present. As such, UBE3A is biallelically expressed in many non-neuronal cell types.
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(Urraca, Hope et al. 2018) indicate increased levels of UBE3A transcript and protein in
the brains of Dup15q individuals, suggesting increased UBE3A-dependent protein
degradation as the primary cause of Dup15q phenotypes.
The primary role of UBE3A is to function an E3 ubiquitin ligase that targets
particular substrate proteins in the cell for degradation by the ubiquitin proteasome. In the
presence of an E2 ligase and a substrate protein, the catalytic cysteine residue in the
UBE3A HECT domain forms a thioester bond with ubiquitin before transferring the
ubiquitin to lysine residues on the substrate protein. UBE3A preferentially forms K48
linked polyubiquitin chains on substrate proteins in a stepwise manner, targeting these
proteins for degradation by the 26S proteasome (reviewed in Scheffner and Kumar 2014).
Consistent with UBE3A being present in both the cytosol and the nucleus, ubiquitin
substrates of UBE3A have been reported from both cellular compartments including
RING1B/RNF2 from the nucleus and RPN10/PSMD4 and Ephexin V from the cytosol,
among other proteins (LaSalle, Reiter et al. 2015). Additionally, UBE3A has been
reported to ubiquitinate substrate proteins without targeting them for degradation,
possibly altering their subcellular localization or function (Reiter, Seagroves et al. 2006,
Ramirez, Lectez et al. 2018). In another role independent of its ubiquitin ligase function,
UBE3A can also act as a transcriptional co-activator. In the nucleus, UBE3A induces
transcription of nuclear hormone receptors (Nawaz, Lonard et al. 1999) and GTP
cyclohydrolase 1 (Ferdousy, Bodeen et al. 2011), an enzyme regulating monoamine
synthesis. Initial disease focused investigations of UBE3A proposed the concept that a
single UBE3A substrate may be identified to explain the pathology of both AS and
Dup15q. Despite a growing list of known UBE3A interacting proteins, no one substrate
can fully explain both disorders and the complexity of UBE3A regulation remains
enigmatic.
HECT and RLD Containing E3 Ubiquitin Ligase 2 (HERC2)
A second ubiquitin ligase, HERC2, is also located within PWACR and is
duplicated in all individuals with Dup15q. The rjs (runty jerky sterile) mouse, named for
its jerky gait, reduced growth, sterility, and maternal behavioral defects carries a loss of
function mutation in Herc2 (Lehman, Nakatsu et al. 1998), demonstrating a role for
HERC2 in normal neuronal development. HERC2 is a large protein consisting of 4834
amino acids and multiple protein domains and is expressed throughout the brain,
including the cortex, hippocampus, and cerebellum (Cubillos-Rojas, Schneider et al.
2016). Similar to UBE3A, the C-terminus of HERC2 contains a catalytic HECT domain
responsible for transferring ubiquitin moieties to substrate proteins. HERC2 also
functions in the nucleus to facilitate DNA repair in response to DNA double strand
breaks (Bekker-Jensen, Rendtlew Danielsen et al. 2010), ubiquitinates and causes the
degradation of the deubiquitinating enzyme USP33 (Chan, den Besten et al. 2014), and
regulates the integrity of the centrosome (Al-Hakim, Bashkurov et al. 2012). In addition
to the HECT domain, HERC2 contains 3 RCC1-like domains (RLD), consisting of
regulator of chromosome condensation-1 (RCC1) repeats. HERC2 is known to physically
interact with UBE3A at the protein level through the RLD2 domain and stimulates
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UBE3A ubiquitin ligase activity independent of the HECT domain of HERC2 (Kuhnle,
Kogel et al. 2011). The interaction between UBE3A and HERC2 has largely been studied
in vitro using biochemical methods, so how these two proteins interact to generate
Dup15q phenotypes is still unknown.
GABA Receptors
A cluster of GABA receptors, including GABRA5, GABRB3, and GABRG3 are
present within breakpoints 2-3 in the 15q11.2-q13.1 region and are duplicated in all cases
of Dup15q. Spontaneous beta oscillations detected in electroencephalograms (EEGs) of
Dup15q individuals, reminiscent of an EEG pattern generated by GABAergic promoting
benzodiazepines and barbiturates, suggests altered GABAergic signaling in Dup15q
syndrome (Urraca, Cleary et al. 2013, Frohlich, Senturk et al. 2016). Researchers often
implicate the duplication of these GABA receptors in Dup15q epilepsy, yet robust
evidence is lacking. Missense variants that impair GABRA5 and GABRB3 receptor
activity are associated with early onset epilepsy (Butler, Moody et al. 2018), however
missense variants are not the same as extra gene copies. Furthermore, 15q11.2-q13.1
copy number does not correlate with GABA receptor transcript levels (Scoles, Urraca et
al. 2011, Urraca, Hope et al. 2018), making it unclear how extra copies of these receptors
tie into Dup15q syndrome phenotypes.
Related Genetic Disorders
Paternal Interstitial Dup15q
Individuals carrying paternally derived interstitial duplications present clinically
with a more variable phenotype compared to maternal duplications. In addition,
paternally derived duplications display incomplete penetrance, as some completely
unaffected individuals have been identified in pedigrees where this duplication was
inherited and not de novo in origin (Cook, Lindgren et al. 1997). Parasomnias are a
consistent phenotype observed in paternal Dup15q individuals, however ASD and IQ
levels can be more variable (Urraca, Cleary et al. 2013). In a cohort of 522 ASD patients,
one individual was identified carrying a paternal interstitial duplication of 15q11.2-q13.1
while no maternally derived interstitial cases were found (Depienne, Moreno-De-Luca et
al. 2009), implying that paternal duplications may also cause ASD, although with
variable expressivity and penetrance. Cases of paternally derived triplications have also
been reported. These individuals display phenotypes more consistent with maternal
duplications, including developmental delay, hypotonia, language deficits, and seizures
(Hogart, Wu et al. 2010), suggesting that genes within the duplication, other than the
neuronally maternally imprinted UBE3A gene, can contribute to the disease phenotype
when elevated at higher levels. Additionally, glial cells biallelically express UBE3A and
glial UBE3A overexpression may contribute to the seizure phenotype of paternal
interstitial triplication cases where glia, but not neurons, express two extra copies of
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UBE3A. Seizure prevalence increases with 15q11.2-q13.1 copy number regardless of the
parent of origin, implying that elevated levels of UBE3A in glia could be associated with
the seizure phenotype. However, the impact of glial UBE3A overexpression has gone
largely unexplored.
Angelman Syndrome (AS)
Maternal deletions of 15q11.2-q13.1, the reciprocal non-homologous allelic
recombination event to the duplications resulting in Dup15q syndrome, are the most
common cause of AS. However, maternally inherited loss of function mutations in
UBE3A, paternal uniparental disomy of chromosome 15, or imprinting defects rendering
the PWSIC unmethylated can also cause AS (LaSalle, Reiter et al. 2015). Regardless of
the molecular genetic event, the underlying molecular cause of AS is the loss of UBE3A
expression in neurons. AS is clinically characterized by microcephaly, hypotonia and
motor delay, sleep disturbances, and the specific behavioral phenotype of excessive
laughter (Buiting, Williams et al. 2016). Similar to Dup15q, AS individuals have high
rates of epilepsy, although these seizures are distinct by EEG from the types of seizure
observed in Dup15q syndrome and can be managed well with certain anti-epileptics
(Pelc, Boyd et al. 2008, Shaaya, Grocott et al. 2016). Seizures are less severe in UBE3A
loss-of-function, uniparental disomy, or methylation defect cases compared to deletion
cases (Minassian, DeLorey et al. 1998, Frohlich, Miller et al. 2019) suggesting that genes
other than UBE3A within the 15q11.2-q13.1 region impact the epilepsy phenotype.
HERC2 Mutations
Loss of function HERC2 mutations can also generate AS-like phenotypes. Three
separate cohorts with developmental delay, ASD, and Angelman-like features have been
identified and individuals carried homozygous mutations in HERC2 that either reduced
HERC2 protein stability or deleted large sections of HERC2 including the RLD2 domain
that stimulates UBE3A ubiquitin ligase activity (Puffenberger, Jinks et al. 2012, Harlalka,
Baple et al. 2013, Morice-Picard, Benard et al. 2016)). The overlapping phenotypes
between HERC2 loss of function mutations and AS provides further evidence for the
interaction between UBE3A and HERC2 in vivo and implies that HERC2 protein may be
necessary for the normal function of UBE3A. The physical location of the HERC2 gene
within the PWACR that is duplicated in Dup15q and deleted in most cases of AS further
implies that HERC2 may be a modifier of the phenotypes observed in both of these
disorders.
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Dup15q Insights from Model Systems
Mouse Models
The animal model with the best face validity of Dup15q is a mouse carrying an
interstitial duplication of 6.3 Mb of mouse chromosome 7, a region syntenic to the
15q11.2-q13.1 region in humans. Mice carrying paternally inherited duplications
displayed ASD-like behaviors including reduced social interactions, behavioral
inflexibility, and lower levels of serotonin in the cortex (Nakatani, Tamada et al. 2009,
Nakai, Nagano et al. 2017). However, these phenotypes were not observed in maternally
inherited duplications which is inconsistent with the parent of origin effect in humans.
This mouse model does however suggest that genes other than Ube3a or elevation of
Ube3a in non-neuronal cell types impacts the phenotypes associated with Dup15q.
Mouse models overexpressing only Ube3a have also been generated. The first
model carried extra copies of C-terminal FLAG tagged Ube3a and recapitulated ASDlike behaviors (Smith, Zhou et al. 2011), but the addition of a FLAG tag to the Cterminus of Ube3a rendered the protein catalytically inactive, and this data has not been
reproducible by other groups. A second mouse was generated by the same group
overexpressing untagged Ube3a and again they observed sociability deficits. These mice
had decreased sociability when seizures were chemically induced, however these mice
did not show spontaneous seizures nor reduced seizure threshold (Krishnan, Stoppel et al.
2017). A second group generated mice overexpressing Ube3a under control of the
Camk2a promoter and mice displayed anxiety-like behavior, learning deficits, and
reduced seizure threshold to pentylenetetrazol. However, ASD-like behaviors and
spontaneous seizures were not observed (Copping, Christian et al. 2017). Taken as a
whole, data from mouse models suggests that elevated levels of Ube3a in neurons may
underlie the ASD-like and cognitive impairment aspects of Dup15q syndrome, however
neuronal Ube3a elevation does not appear to be responsible for epilepsy in Dup15q.
Drosophila Models
Despite the divergence of Homo sapiens and Drosophila melanogaster over 700
million years ago, 46% of fly genes have an ortholog to at least one gene in the human
genome (Shih, Hodge et al. 2015) and approximately 75% of human disease genes have a
clear fly ortholog (Reiter, Potocki et al. 2001). Based on the high degree of conservation
of disease genes, quick generation time, and the number of tools available (Ugur, Chen et
al. 2016), fruit flies are an attractive system to investigate human disease. Drosophila
have a single ortholog of UBE3A, termed Dube3a, which is 40% conserved across the
whole protein and greater than 70% identical in the HECT domain compared to human
UBE3A (Reiter, Seagroves et al. 2006). Based on the conservation between Dube3a and
UBE3A, Drosophila is a suitable model system and multiple fly models have been
generated to investigate UBE3A function.
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By taking advantage of the GAL4/UAS system (Duffy 2002), a handful of direct
ubiquitin ligase substrates of Dube3a have been identified using flies, including the RhoGEF Pbl (Reiter, Seagroves et al. 2006), the Na+/K+ ATPase ATPα (Jensen, Farook et al.
2013), and the proteasomal proteins Rpn10 (Lee, Ramirez et al. 2014) and Rngo
(Ramirez, Lectez et al. 2018). Elevated levels of Dube3a in motor neurons results in
increased excitability and reduced capacity to maintain high firing frequencies (Valdez,
Scroggs et al. 2015), and neuronal overexpression throughout the fly brain results in
learning defects in an aversive phototaxis suppression assay (Chakraborty, Paul et al.
2015). Insights have also been made from Dube3a null mutant flies. Loss of Dube3a
results in impaired locomotion and circadian rhythm defects (Wu, Bolduc et al. 2008) and
decreased arborization in the dendrites of peripheral neurons (Lu, Wang et al. 2009),
recapitulating some aspects of Angelman syndrome. Additionally, a lesser known
transcriptional co-activation function of Dube3a has been investigated in Drosophila in
which even a ubiquitin ligase defective form of Dube3a elevates levels of
tetrahydrobiopterin, the rate limiting cofactor in the synthesis of monoamines (Ferdousy,
Bodeen et al. 2011). Despite a number of models that focus on neuronal functions for
UBE3A and the substrates that have been identified, no model has yet successfully
recapitulated the seizure phenotype observed in Dup15q syndrome.
Hypothesis and Specific Aims
UBE3A plays a key role in Dup15q syndrome, yet the mechanism underlying
Dup15q phenotypes, particularly seizures, remains poorly understood. First, we wanted to
determine the imprinting status of Dube3a in Drosophila melanogaster. Next, we
hypothesized that genes located within the 15q11.2-q13.1 duplication region other than
UBE3A act alone or synergistically with UBE3A to impact Dup15q phenotypes. Based on
the known interaction between UBE3A and HERC2, we decided to investigate the
interaction between these two proteins. Finally, we hypothesized that cells other than
neurons underlie aspects of Dup15q syndrome, particularly the seizure phenotype. To test
these hypotheses, we proposed the following specific aims:
1. Determine if Dube3a is imprinted in Drosophila melanogaster. Data from these
experiments are presented in Chapter 2.
2. Investigate if Dube3a and HERC2 interact synergistically to generate Dup15q
phenotypes. Data from these experiments are presented in Chapter 3.
3. Identify if non-neuronal cells, specifically glia, are involved in the seizures
observed in Dup15q syndrome. Data from these experiments are presented in
Chapters 4 and 5.
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CHAPTER 2.

THE DROSOPHILA MELANOGASTER HOMOLOG OF UBE3A
IS NOT IMPRINTED IN NEURONS1
Introduction

Angelman syndrome (AS) results from neuronal loss of maternally expressed
ubiquitin protein ligase E3A (UBE3A) in neurons (Kishino, Lalande et al. 1997).
Maternal deletions of chromosome 15q11.2-q13.1 encompassing UBE3A are the most
common cause of AS. However, maternally-inherited loss-of-function (LOF) point
mutations in UBE3A, imprinting defects, or paternal uniparental disomy also cause AS
(LaSalle, Reiter et al. 2015). The first evidence for imprinted expression of UBE3A in
neurons arose from the observation that maternally derived deletions of 15q11.2-q13.1
cause AS (Knoll, Nicholls et al. 1989) and that UBE3A displays maternal allele-specific
expression in human brain samples (Rougeulle, Glatt et al. 1997). In mice, Ube3a is
expressed from the maternal allele in hippocampal, cerebellar, and olfactory bulb mitral
neurons (Albrecht, Sutcliffe et al. 1997). Ube3a is biallelically expressed in neurons born
from stem cells in the adult mammalian brain and immature neurons early in
development (Dindot, Antalffy et al. 2008). Ube3a expression shifts from biallelic to
maternal allele specific as neurons mature (Judson, Sosa-Pagan et al. 2014). UBE3A is
biallellically expressed in human induced pluripotent stem cells and neuronal
differentiation results in paternal silencing of UBE3A (Chamberlain, Chen et al. 2010). In
contrast to neurons, glial cells in the mammalian brain biallelically express UBE3A
(Yamasaki, Joh et al. 2003, Dindot, Antalffy et al. 2008, Judson, Sosa-Pagan et al. 2014).
Imprinted expression of UBE3A in neurons is a complex mechanism mediated by
the expression of a UBE3A-antisense transcript (UBE3A-AS) that interferes with
expression of the sense UBE3A full-length transcript. The Prader-Willi syndrome
imprinting center (PWS-IC) is maternally methylated and silenced due to an upstream
Angelman syndrome imprinting center (AS-IC) that epigenetically alters the maternal
PWS-IC in the female germline via a transcriptional mechanism, leaving maternal PWSIC nonfunctional post-fertilization (Kelsey and Feil 2013). Downstream from the PWSIC is the SNURF-SNRPN locus, and the SNRPN transcript progresses through a cluster of
snoRNAs and spliced host genes, terminating as UBE3A-AS. The expression of UBE3AAS on the opposite strand of UBE3A interferes with UBE3A expression on the paternal
allele and is the mechanism for paternal UBE3A silencing (LaSalle, Reiter et al. 2015).
Although it is well-established that UBE3A is imprinted in the mature neurons of
human and mouse brain, it is unclear if UBE3A is imprinted in the brains of nonmammalian species including the model invertebrate organism Drosophila melanogaster.
Flies have a single UBE3A homolog (Reiter, Seagroves et al. 2006), Dube3a, and
mutations in this gene give rise to various phenotypes independent of the parental origin
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of the mutation (Wu, Bolduc et al. 2008). Recently, it was reported that Dube3a is
preferentially expressed from the maternal allele in flies (Chakraborty, Paul et al. 2015).
However, there is a lack of synteny between fly and human genomes at the
UBE3A/Dube3a loci and there is no prior evidence for allele specific expression in flies.
Given that flies do not have a documented imprinting center, differentially methylated
region or UBE3A-AS, we set out to definitively determine if Dube3a is, in fact,
preferentially expressed from the maternal allele in fly brain. Using behavioral analysis,
electroretinograms (ERGs) and allele-specific coding single nucleotide polymorphism
(SNP) expression studies, we found no evidence for Dube3a imprinting in flies. Both
maternal and paternal Dube3a alleles are co-expressed in fly brain.
Methods
Drosophila Stocks
All flies were maintained at 25ºC on a 12-hour light/dark cycle and raised on
standard corn meal media (Bloomington Stock Center). Dube3a15b is a null loss-offunction (LOF) allele that produces a truncated transcript that does not make functional
Dube3a protein (Reiter, Seagroves et al. 2006). w1118 flies were used as controls. The
following Drosophila Genetic Reference Panel (DGRP) lines (Mackay, Richards et al.
2012) were also obtained from the Bloomington Drosophila Stock Center: RAL-21,
RAL-239, RAL-313, and RAL-517 (stock numbers 28112, 28161, 25180, and 25197,
respectively).
Genome Comparisons
Genomic regions surrounding Dube3a in Drosophila melanogaster were
compared to human UBE3A using the UCSC genome browser (http://genome.ucsc.edu/)
(Kent, Sugnet et al. 2002). We used fly BDGP Release 6 + ISO1 MT/dm6 assembly and
human GRCh38/hg38 assembly for comparisons.
Climbing Assay
Climbing assays were performed as previously described (Hatfield, Harvey et al.
2015). In brief, 3 flies of each genotype at 5 d post-eclosion were transferred to empty
vials and allowed 1 min to acclimate. Flies were tapped to the bottom of the vial and the
time was measured for the first fly to climb past a 4 cm vertical mark. Three trials were
averaged per group of flies with 1 min intervals.
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Electroretinogram (ERG)
ERGs were performed as previously described (Vilinsky and Johnson 2012), with
modifications. Flies were immobilized on ice for 2 min, transferred to a glass slide, and
held in place with dental wax. Tungsten wire electrodes were gently inserted into the
right eye (recording electrode) and abdomen (ground electrode). Data was recorded using
a Model 1800 Microelectrode AC Amplifier (A-M Systems), digitized with a Micro3
1401 digitizer (Cambridge Electronic Design), and analyzed with Spike2 software
(Cambridge Electronic Design). Fly eyes were stimulated using 1-s light pulses from a 5
mm white LED (Radioshack).
Statistical Analysis
Significance testing was performed by 1-way ANOVA analysis. All statistics
were performed using Prism version 6.0 (GraphPad).
Allele-specific Dube3a Sequencing
Using the DGRP and the UCSC Genome browser of DGRP2 data
(dgrp2.gnets.ncsu.edu), we selected 3 lines with single nucleotide polymorphisms (SNPs)
in coding exons of Dube3a. RAL-21 was used as a reference line, and lines RAL-313,
RAL-239, and RAL-517 harbored G78T, G117T, and C171A SNPs, respectively. We
performed reciprocal crosses and extracted RNA from heads for cDNA synthesis. Totals
of 20-30 fly heads from each cross were removed and homogenized in TRI Reagent
Solution (Ambion). Total RNA was extracted using Directzol RNA MiniPrep Plus (Zymo
Research Corp) according to the manufacturer’s instructions, which include a DNAse
step to remove genomic DNA. RNA was converted to cDNA using Transcriptor First
Strand cDNA Synthesis Kit (Roche). A 950 bp fragment of Dube3a encompassing our
chosen SNPs was PCR amplified with Phusion polymerase (Thermofisher Scientific)
using the following forward and reverse primers, respectively: 5’ATGAACGGTGGCGGGG-3’, and 5’-CGCTGCTTTGGGATGAACAC-3’. PCR
products were sent for Sanger sequencing (GENEWIZ) using the following sequencing
primer: 5’-AATGAAGCTCTTGCCCAGTC-3’. Sequence data was analyzed using
CodonCode Aligner (CodonCode Corporation).
Results
Genomic Regions Surrounding Fly and Human UBE3A are Not Syntenic
The UCSC genome browser was used to examine genomic features surrounding
fly Dube3a and human UBE3A (Figure 2-1). In flies, the 2 genes flanking Dube3a are
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Figure 2-1. The genomic region surrounding UBE3A is not syntenic between flies
and humans.
Images from the UCSC genome browser (http://genome.ucsc.edu/) for the 10 kb region
surrounding Dube3a in flies (A) and 1 Mb surrounding UBE3A in humans (B; note: the
SNORD cluster has been truncated). In flies, there is no cluster of snoRNAs or the
presence of SNURF/SNRPN upstream or downstream of Dube3a. There is also no RNA
transcript that overlaps with Dube3a (A; red bars). In humans, note the presence of
SNHG14 (UBE3A-AS) that overlaps with UBE3A transcript (B, boxed region).
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Plod and CG7600, which have human homologs located at 7q22.1 and 8q24.13,
respectively. No antisense transcript has been reported to interfere with Dube3a
expression at this locus (Figure 2-1A). In contrast, the human SNHG14 (UBE3A-AS)
transcript clearly overlaps with the UBE3A transcript (Figure 2-1B). Based on these data,
it appears unlikely that fly Dube3a is preferentially expressed from the maternal allele as
the surrounding genomic region is not syntenic to the human UBE3A region. There are no
antisense transcripts detected across the Dube3a locus.
Climbing Behavior is Not Dependent Upon Maternal Dube3a Expression
Previous work demonstrated climbing deficiencies in homozygous Dube3a15b
(Dube3a null) flies, as significantly fewer Dube3a15b flies climbed 3 cm within 3 s (Wu,
Bolduc et al. 2008). Our experiments showed a significant effect of Dube3a15b allele on
climbing ability (One-way ANOVA, F(3,20) = 6.99, P = 0.0021). Tukey’s multiple
comparisons test indicated that Dube3a15b homozygous flies took significantly longer to
climb to a height of 4 cm compared to control w1118 flies, confirming previous reports of
climbing defects in homozygous Dube3a15b flies. Flies that inherited this Dube3a15b allele
through either the paternal or maternal germline displayed no differences in climbing
behavior from controls (Figure 2-2). These data indicate that a single copy of functional
Dube3a of either paternal or maternal origin is sufficient for normal climbing behavior
and provide evidence that Dube3a is neither imprinted nor preferentially expressed from
the maternal allele.
Synaptic Transmission Defects in Dube3a15b Mutants are Present Independent of
Parent of Origin
We previously demonstrated impaired synaptic transmission in Dube3a15b flies at
the neuromuscular junction (Valdez, Scroggs et al. 2015). Here we investigate neuronal
activity and synaptic transmission in photoreceptor neurons of the fly eye using ERGs. In
the ERG signal, the “on” and “off” transients are indirect measures of synaptic
transmission, while the photoreceptor potential is a measure of photoreceptor neuron
depolarization (Ugur, Chen et al. 2016). Control w1118 flies displayed robust on/off
transients and large photoreceptor potentials (Figure 2-3, top trace). The Dube3a15b
mutation significantly affected both on transients (One-way ANOVA, F(3,32) = 11.75, P ≤
0.0001) and off transients (One-way ANOVA, F(3,32) = 22.63, P ≤ 0.0001). Tukey’s post
hoc multiple comparisons testing indicated that the presence of the Dube3a15b allele
(either homozygous or heterozygous) reduced both on and off transients regardless of the
parent of origin of the mutant allele as compared to control flies. No significant
differences were observed in on/off transients among Dube3a15b allele carrying flies
(heterozygous or homozygous). We observed no effect of this mutation on photoreceptor
potentials (One-way ANOVA, F(3,32) = 2.88, P = 0.057). Thus, the Dube3a15b allele
appears to effect synaptic transmission components of the ERG signal without interfering
with the photoreceptor neuron depolarization. Haploinsufficiency for Dube3a is also
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Figure 2-2. Only Dube3a15b homozygous LOF flies display climbing deficits.
At 5 days of age, flies were tested for motor function. Homozygous Dube3a15b flies had
significantly impaired climbing ability compared to control w1118 flies (P = 0.0021).
Paternally or maternally inherited Dube3a15b heterozygotes did not differ from controls in
climbing ability. Data are presented as mean with standard error, n = 6 for all groups.
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Figure 2-3. Heterozygous Dube3a15b flies have reduced on/off transients in the
ERG signal independent of parent of inheritance.
Control w1118 flies (n = 12) display robust on/off transients that are significantly reduced
in paternal (n = 6), maternal (n = 7), and homozygous Dube3a15b (n = 11) flies (On
Transient, P < 0.0001; Off transient, P < 0.0001). Note that the Dube3a15b mutation does
not impair photoreceptor potentials. Data are presented as means with standard error.
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sufficient to decrease synaptic transmission regardless of the parental origin of the
mutation, thus indicating that Dube3a is not preferentially expressed from either allele in
the brain.
Allele-specific Expression of Dube3a
To investigate Dube3a allele specific expression at the molecular level, we
performed reciprocal crosses with flies from the DGRP containing coding SNPs in
Dube3a. Using the UCSC genome browser of the DGRP2 data (Mackay, Richards et al.
2012) located at dgrp2.gnets.ncsu.edu, we selected coding SNPs located in Dube3a.
Three separate DGRP lines were used; RAL-239(G117T), RAL-313(G78T), and RAL517(C171A), which each contain coding SNPs in Dube3a as compared to the reference
line RAL-21. Female RAL-239 crossed to male RAL-21 and female RAL-21 crossed to
male RAL-239 showed 2 similarly sized (~50%) peaks in the chromatogram at position
117 in the Dube3a cDNA sequence (Figure 2-4A). Similar results were observed
between reciprocal crosses of RAL-313 crossed to RAL-21 at position 78 (Figure 2-4B),
and RAL-517 and RAL-21 at position 171 (Figure 2-4C). These data align with our
previous experiments and support the conclusion that Dube3a is biallelically expressed in
the fly brain, and neither imprinted nor preferentially expressed from the maternal allele.
Discussion
Our behavioral and molecular analyses indicate that neural expression of Dube3a
alleles is independent of parental origin. Using the same Dube3a15b allele as Wu et al., we
confirmed climbing deficiency in Dube3a homozygous LOF flies (Wu, Bolduc et al.
2008). Here we demonstrated that paternally or maternally-deficient Dube3a15b flies do
not display climbing difficulties, indicating that one functional copy of Dube3a is
sufficient for normal motor function independent of parent of origin. Our lab previously
demonstrated synaptic transmission deficits at the neuromuscular junction in Dube3a15b
homozygous flies (Valdez, Scroggs et al. 2015), and we confirmed synaptic transmission
deficits here using ERGs. In our previous work at the 3rd instar neuromuscular junction,
we reported that excitatory junction potentials decreased in amplitude faster in Dube3a
LOF flies in comparison with controls (Valdez, Scroggs et al. 2015), possibly due to a
depletion of synaptic vesicles in the readily releasable pool (Desai-Shah and Cooper
2009). Here we show reductions in on/off transients in the ERG signal, which may also
be due to a depletion of synaptic vesicles. Regardless, on/off transients were reduced in
Dube3a homozygous and reciprocal heterozygous Dube3a15b flies, supporting the
conclusion that Dube3a is neither imprinted nor preferentially expressed and that Dube3a
haploinsufficiency is sufficient to cause synaptic transmission defects. The strongest
piece of evidence indicating that Dube3a is not imprinted in flies comes from sequencing
several different wild-type alleles of Dube3a. Reciprocal crosses for 3 separate wild-type
Dube3a alleles indicated similar, if not identical, expression of both maternally and
paternally-inherited alleles.
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Figure 2-4. Sanger sequencing chromatograms of different wild-type Dube3a
coding SNPs does not indicate imprinting or preferential allele specific expression.
Total fly head RNA from reciprocal crosses with different coding SNPs present in
Dube3a was DNase I treated and converted to cDNA. Sanger sequencing was performed
on amplified cDNA using primers flanking the SNP to identify the expression of
paternally or maternally inherited Dube3a alleles. In all alleles tested, we found similar
expression levels of maternally and paternally inherited coding region alleles as indicated
by 2 peaks at each SNP of the same height (arrows).
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In contrast to Chakraborty et al. (Chakraborty, Paul et al. 2015), we found no
evidence that Dube3a is imprinted or preferentially expressed from the maternal allele in
Drosophila melanogaster. On the other hand, our data is compatible with previously
reported learning deficits in Dube3a maternally-deficient flies since we found that
Dube3a haploinsufficiency results in ERG on/off transient deficiencies regardless of
parental origin. As the UBE3A imprinting mechanism in mature mammalian neurons is
complex and similar PWS/AS-ICR or antisense transcripts have not been detected in
Drosophila, our behavioral, electrophysiological, and Dube3a allele-specific expression
data suggest that Dube3a is neither imprinted nor preferentially expressed in fruit flies.

21

CHAPTER 3.

INVESTIGATING SYNERGISTIC INTERACTIONS BETWEEN
DUBE3A AND HERC2
Introduction

Autism spectrum disorder (ASD) has a prevalence of 1 in 59 (Baio, Wiggins et
al. 2018) and the identification of causal genes has been limited. The heritability of ASD
is estimated to be 83% (Sandin, Lichtenstein et al. 2017), indicating that ASD is highly
heritable. However, causal genes have only been identified in approximately 25% of
individuals and each gene mutation/variant is individually rare and only explains 1-2% of
cases (Yoo 2015). Perturbation of multiple genes in the same biological pathway may be
necessary to generate ASD phenotypes (Noh, Ponting et al. 2013), which may contribute
to the lack of identified ASD genes. De novo copy number variations (CNVs) resulting
from genomic duplications and deletions are prevalent in ASD (Sebat, Lakshmi et al.
2007, Pinto, Pagnamenta et al. 2010, Moreno-De-Luca, Sanders et al. 2013). CNVs
harboring multiple genes known to interact with one another that cause elevated rates of
ASD are, therefore, good candidates to identify genes contributing to ASD risk.
Recurrent de novo duplications of the 15q11.2-q13.1 region are associated with
increased risk for ASD (Cook, Lindgren et al. 1997, Sanders, Ercan-Sencicek et al. 2011,
Malhotra and Sebat 2012, Moreno-De-Luca, Sanders et al. 2013). Two genes within the
15q duplication, ubiquitin protein ligase E3A (UBE3A), an E3 ubiquitin ligase involved
in protein degradation and HECT and RLD domain containing E3 ubiquitin protein ligase
2 (HERC2), encode proteins that physically interact with one another. HERC2 stimulates
the ubiquitin ligase activity of UBE3A, independent of its own ubiquitin ligase function,
through an interaction between the RCC1-like domain 2 (RLD2) of HERC2 with the Nterminus of UBE3A (Kuhnle, Kogel et al. 2011, Galligan, Martinez-Noel et al. 2015).
Individuals with loss-of-function point mutations in HERC2 present clinically with
Angelman syndrome-like phenotypes (Puffenberger, Jinks et al. 2012, Harlalka, Baple et
al. 2013, Morice-Picard, Benard et al. 2016), providing further evidence that UBE3A and
HERC2 function in similar biological pathways. Aside from these in vitro biochemical
studies the downstream molecular consequences of the interaction between UBE3A and
HERC2 has not be thoroughly investigated.
To investigate the interaction between UBE3A and HERC2, and to determine if
they act synergistically to cause Dup15q-associated phenotypes including ASD, we
turned to Drosophila and the GAL4/UAS expression system (Duffy 2002). In this
chapter, we present data from flies overexpressing Dube3a alone, HERC2 alone (the fly
UBE3A and HERC2 orthologs, respectively), or both genes simultaneously to reveal the
contributions of each gene alone and synergistically to several behavioral phenotypes. By
taking a whole organism approach we are able to assay the interaction between Dube3a
and HERC2 in a fully intact organism which accounts for developmental effects and
interactions among different cell types and allows for the analysis of complex behaviors
that are not possible to investigate in vitro.
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Methods
Fly Stocks
Flies were raised on standard corn meal media (Blooming Drosophila Stock
Center) and maintained on a 12-h light/dark cycle at 25°C. The UAS-HERC2 enhancer
piracy line (BDSC # 33296) and PDF-GAL4 (BDSC #6900) were obtained from the
Bloomington Drosophila Stock Center (Bloomington, IN). The UAS-Dube3a line was
described previously (Reiter, Seagroves et al. 2006), and c155-GAL4 was generously
donated by Dr. Hugo Bellen. Since the c155-GAL4 driver and the HERC2 enhancer
piracy element are both present on the X chromosome, all experiments were performed
on female flies.
RLD2 Domain Comparison Between Human and Fly HERC2
Amino acid sequences of the RLD2 domain from human and fly HERC2 were
compared using the Clustal Omega multiple sequence alignment tool (Sievers, Wilm et
al. 2011). The RLD2 domain of human HERC2 consists of amino acids 2958-3326
(UniProt Accession #O95714) and the RLD2 domain of fly HERC2 consists of amino
acids 2985-3352 (UniProt Accession #Q9VR91).
Quantitative Real-time Polymerase Chain Reaction (qRT-PCR)
Total head mRNA was extracted in TRI Reagent (Applied Biosystems) and RNA
was extracted and purified using the Directzol RNA Miniprep Plus kit (Zymo Research
Corp) according to the manufacturer’s instructions. Purity and concentration were
verified using a NanoDrop spectrophotometer (ThermoFisher Scientific). Assays were
performed in triplicate on a Roche LC480 thermocycler with the following cycling
parameters: 95°C for 5 m followed by 40 cycles of 95°C for 10 s, 60°C for 30 s, and
72°C for 10 s during which fluorescence was measured. Crossing point (Cp) values were
calculated with the absolute quantification algorithm (Roche), and average Cp values for
three technical replicates were calculated, normalized to TATA-binding protein (tbp), and
fold change was calculated with the (2)-∆∆Cp method. The following primers were used
with probe #25 from the Universal Probe Library (UPL) for HERC2: F 5’TCACCTGGTTCTGGGAGGT-3’, R 5’-CGAACCGCAGGAATAGAGAG-3’. For tbp,
the following primers were used with UPL probe #109: F: 5’ACAGGGGCAAAGAGTGAGG-3’, R 5’-CTTAAAGTCGAGGAACTTTGCAG-3’.
Quantitative Western Blot Analysis
Western blots were performed as previously described (Hope, LeDoux et al.
2017). Fly heads were removed and homogenized in radio-immunoprecipitation assay
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(RIPA) buffer with complete protease inhibitor (Roche), and 20 µg of fly head protein
was loaded into each lane of a 1.5 mm NuPAGE Bis-Tris 4-12% gradient gel (Invitrogen)
and transferred to a PVDF membrane (Millipore). Membranes were blocked with 5%
milk, 3% bovine serum albumin, and 0.1% Tween-20 in phosphate buffered saline.
Primary antibodies used were rat α-Dube3a at 1:4000 (gift from Dr. Janice Fischer) and
goat α-GAPDH at 1:5000 (IMGENEX Cat# IMG-3073). α-goat and α-rat, infrared
secondary antibodies were used at a dilution of 1:15,000. Blots were imaged using the
Odyssey Infrared Imaging System (Li-Cor), analyzed using Image Studio Lite software
(Li-Cor), and all lanes were normalized to GAPDH.
Social Space Assay
Flies 1-3 days of age were collected under CO2 anesthesia and allowed two days
to recover prior to testing. For testing, flies were briefly immobilized by placing on ice
for 2 minutes before transferring into the triangle testing apparatus described previously
(Simon, Chou et al. 2012). Due to reported climbing defects observed in c155>Dube3a
flies (Wu, Bolduc et al. 2008), we performed these assays with the triangles in a
horizontal position. After 30 minutes in the triangle, an image was captured and ImageJ
was used to calculate the nearest neighbor distance between each fly.
Neuromuscular Junction Immunohistochemistry and Image Analysis
NMJ analysis was performed on larvae 5 days post egg laying. Female larvae
were selected by the absence of the developing gonad and dissected in phosphate
buffered saline. Larvae were fixed for 15 minutes in 4% formaldehyde at room
temperature. Larval fillets were blocked and permeabilized with PBS containing 1%
bovine serum albumin and 0.01% Triton X-100, followed by incubation with α-discs
large (DSHB, 4F3) at 1:100. Goat α-mouse 594 secondary antibody (Invitrogen A11005)
was used at 1:500. NMJs innervating muscles 6/7 from hemisegment A3 were imaged
using a laser-scanning confocal microscope (Zeiss LSM 710). Z-stacks through each
NMJ were obtained using a 63X oil-immersion objective at 1024 x 1024 resolution. NMJ
length was calculated using ImageJ (NIH).
Activity Monitoring and Circadian Rhythm Analysis
Female flies were collected on the day of eclosion and entrained for 2 days under
12-hour light/dark cycle. On day 3, individual flies were loaded into glass tubes
containing standard Drosophila corn meal media and stoppered with a small cotton plug.
Locomotor activity was monitored using the Drosophila Activity Monitoring System
(DAMS, Trikinetics). Activity was measured for 3 days during light/dark cycles,
followed by 7 days of activity monitoring during complete darkness (dark/dark) to
measure the freerunning period.
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Data were visualized and analyzed using the ActogramJ plugin for ImageJ
(Schmid, Helfrich-Forster et al. 2011). Actograms were averaged for each genotype (n ≥
4 per genotype), and period length was calculated using the ActogramJ built in Chisquare analysis with a window of 1000-2000 minutes to identify cycle length.
Results
Human and Fly HERC2 Are Highly Conserved Within the RLD2 Domain
The human HERC2 protein is 4834 amino acids in length and contains 8 distinct
domains. Similarly, the Drosophila melanogaster HERC2 protein is 4912 amino acids in
length and contains many of the same domains as human HERC2, including the RLD2
domain (Figure 3-1A). Across the whole protein, human and fly HERC2 are 46.1%
identical, however within the RLD2 domains they share 74.46% identity (Figure 3-1B).
Based on the high conservation between RLD2 domains of human and Drosophila
HERC2, we hypothesize that the RLD2 domain of Drosophila HERC2 should be able to
stimulate Dube3a activity as previously shown in vitro for human HERC2 and UBE3A
(Kuhnle, Kogel et al. 2011).
Drosophila HERC2 Stimulates the Ubiquitin Ligase Activity of Dube3a
In order to overexpress Drosophila HERC2 we obtained an enhancer piracy line
that contains a P-element with a UAS sequence upstream of HERC2 (BDSC #33296,
referred to as UAS-HERC2). Quantitative real-time polymerase chain reaction (qRTPCR) was performed on total head mRNA from c155>HERC2 flies. Compared to control
c155-GAL4 alone, the c155>HERC2 line had a 5.6 ± 1.35-fold elevation of HERC2
transcript, indicating that the UAS-HERC2 line does indeed overexpress HERC2
transcript when crossed to c155-GAL4.
Next, we tested whether fly HERC2 is capable of stimulating the ubiquitin ligase
activity of Dube3a in vivo. There are many potential UBE3A substrates published, but no
one substrate has been accepted in the field as a hallmark of UBE3A ubiquitin ligase
function (LaSalle, Reiter et al. 2015). However, it is well-established that UBE3A
autoubiquitinates itself in trans (Nuber, Schwarz et al. 1998), making Dube3a a viable
target to test for Dube3a activity. We performed western blots for Dube3a levels in flies
overexpressing Dube3a alone, HERC2 alone, or both Dube3a and HERC2
simultaneously with the pan-neuronal GAL4 driver c155-GAL4. Dube3a levels were
significantly dependent upon genotype (Figure 3-2A, B, One-way ANOVA, F(3,8) = 228,
p < 0.0001), and Tukey’s multiple comparisons test (α < 0.05) revealed that
c155>Dube3a flies had elevated levels of Dube3a compared to c155-GAL4 alone flies,
and this increase in Dube3a was reduced upon simultaneous overexpression of HERC2.
Additionally, overexpression of HERC2 alone significantly reduced levels of Dube3a
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Figure 3-1. Human and Drosophila HERC2 proteins are homologous.
A) Domains from human (Homo sapiens, top) and fly (Drosophila melanogaster,
bottom) are indicated across the HERC2 protein. The interaction domain between human
HERC2 and UBE3A is called RLD2. B) Amino acid sequence alignment from the human
and Drosophila RLD2 domain. The RLD2 domain that interacts with UBE3A shares a
high degree of identity at 74.46%.

26

Figure 3-2. Drosophila HERC2 stimulates the ubiquitin ligase activity of Dube3a.
UBE3A/Dube3a autoubiquitinates itself so Dube3a levels can be used as a measure of
Dube3a activity. A) Western blot for levels of Dube3a protein following overexpression
in neurons of Dube3a alone, HERC2 alone, or both HERC2+Dube3a with c155-GAL4.
B) Quantification of western blot signals indicates that Dube3a levels were elevated in
c155>Dube3a as predicted, however upon simultaneous overexpression of HERC2 we
observed reduced levels of Dube3a protein (green bar vs. red bar). Additionally, we
observed reduced Dube3a levels of endogenous Dube3a when only overexpressing
HERC2 alone (black bar vs. blue bar). Data are presented as mean  SEM, n = 3 for all
samples. * = p < 0.05, ** = p < 0.01, *** = p < 0.005, and **** = p < 0.001.
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compared to control c155-GAL4, indicating that overexpression of HERC2 alone reduces
levels of endogenous Dube3a. These data suggest that Drosophila HERC2 is able to
stimulate the ubiquitin ligase of Dube3a in vivo, similar to what occurs in vitro with
mammalian UBE3A/HERC2.
Simultaneous Overexpression of HERC2 and Dube3a Increases Social Spacing
In order to assay ASD-like behavior in flies we performed two assays to measure
social interaction and repetitive/restrictive interests. First, we used a previously published
assay that measures social interaction in which flies are placed in a triangular shaped
apparatus (Figure 3-3A) and allowed to equilibrate their spacing among each other
within a group (Simon et al., 2012). While this assay is typically performed with the
triangle in a vertical orientation, we performed the assay in a horizontal orientation to
avoid confounds from known climbing defects observed in c155>Dube3a flies (Wu,
Bolduc et al. 2008). We observed a significant effect of genotype on the average social
space for each genotype (Figure 3-3B, One-way ANOVA, F(3, 298) = 2.69, p < 0.05). A
Tukey’s multiple comparisons test (α < 0.05) indicated that the only genotype
significantly different from controls was c155>HERC2+Dube3a. Next, we performed a
grooming assay to measure repetitive/restrictive interests. Flies were placed into a
chamber and the time spent grooming during the 5-minute assay period was recorded. We
observed a significant effect of genotype on time spent grooming (One-way ANOVA,
F(3,20) = 12.78, p < 0.0001), and c155>HERC2 flies displayed a significant increase total
grooming time (Tukey’s multiple comparisons test, α < 0.005). These data suggest a
synergistic interaction between Dube3a and HERC2 in generating defects in social
interaction and that elevated levels of only HERC2 impact repetitive/restrictive
behaviors.
Overexpression of HERC2 and Dube3a Impairs Synaptic Morphology at the
Neuromuscular Junction
The Drosophila neuromuscular junction (NMJ) has been used successfully to
dissect how multiple genes located within a CNV contribute to disease pathology (Grice,
Liu et al. 2015). Here, we took a similar approach and upon visualization of the NMJ
with α-DLG staining we observed a significant effect of genotype on NMJ length (Figure
3-4A, B, One-way ANOVA, F(3,21) = 8.79, p < 0.0001). Tukey’s multiple comparisons
test (α < 0.05) indicated that overexpression of HERC2 alone or Dube3a alone did not
significantly affect NMJ morphology. However, simultaneous overexpression of both
HERC2 and Dube3a resulted in significantly reduced NMJ length. These data indicate
that HERC2 and Dube3a act synergistically to influence synaptic phenotypes, while
overexpression of each gene alone does not result in appreciable differences at the NMJ.
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Figure 3-3. Simultaneous overexpression of HERC2 and Dube3a increases social
spacing.
To investigate how Dube3a and HERC2 contribute to ASD-like behaviors we used a
social space assay and a grooming assay to measure the social interaction and repetitive
behavior components of ASD. A) Image of the triangle apparatus used to measure social
spacing in flies. B) Average nearest neighbor for each genotype of flies in the social
space assay. The average social space was significantly increased in
c155>HERC2+Dube3a flies compared to control c155-GAL4 alone flies (One-way
ANOVA, p < 0.05, n ≥ 68 per genotype). C) Average time spent grooming per genotype
during the 5-minute grooming assay. Grooming time was significantly increased in
c155>HERC2 flies compared to all other groups (One-way ANOVA, p < 0.001, n = 6
per genotype). Data are presented as mean  SEM.
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Figure 3-4. Overexpression of HERC2 and Dube3a impairs synaptic morphology
at the neuromuscular junction.
A) Disks large (DLG) staining at the neuromuscular junction (NMJ) of segment A3,
muscles 6/7 in 3rd instar larva (scale bar is 25 m. B) Quantification of NMJ length for
each genotype. c155>HERC2+Dube3a NMJs displayed significantly reduced NMJ
length compared to control NMJs (One-way ANOVA, p < 0.001, n = 6 per genotype).
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Co-overexpression of HERC2 and UBE3A in PDF Neurons Impairs Circadian
Rhythms
Individuals with Dup15q often suffer from sleep problems and the AS deletion is
associated with defects in BMAL1, a protein known to regulate circadian rhythm
(Gossan, Zhang et al. 2014, Shi, Bichell et al. 2015). Here we investigated whether
elevated levels of HERC2 or Dube3a impaired circadian rhythms in Drosophila. In these
experiments we restricted overexpression to pigment dispersing factor (PDF) positive
neurons using the PDF-GAL4 driver since these cells are known to critically regulate
circadian rhythms in flies (Renn, Park et al. 1999). Flies were entrained to a 12-hour
light/dark cycle for 3 days and subsequently placed in complete darkness to monitor their
freerunning period. Control PDF-GAL4 alone flies exhibited robust circadian rhythms in
the light/dark cycle and the dark/dark cycle, with period lengths averaging 1440 minutes
and 1410 minutes, respectively (Figure 3-5A, B). PDF>Dube3a flies presented a robust
period length averaging 1440 minutes in both the light/dark cycle and in the dark/dark
cycles, with no shortening of the freerunning period observed (Figure 3-5B).
PDF>HERC2 flies displayed similar periods to the control group, with periods of 1440
minutes in length in the light/dark cycle and periods of 1410 minutes in the dark/dark
cycle (Figure 3-5B). In PDF>HERC2+Dube3a flies, periods were of similar length
compared to the control group, averaging 1440 minutes in length, however in the
dark/dark cycle no significant periodicity was detected (Figure 3-5B). These data suggest
that simultaneous co-overexpression of both HERC2 and Dube3a interact synergistically
to significantly alter circadian rhythms in Drosophila during the dark/dark freerunning
period.
Discussion
Here, we investigated the interaction between Dube3a and HERC2 in vivo and the
role that neuronal overexpression of each gene individually or simultaneously plays in
generating phenotypes associated with Dup15q syndrome. Drosophila and human
HERC2 proteins share a high degree of sequence identity and the data presented here
suggests that Drosophila HERC2 increases the ubiquitin ligase function of Dube3a in
vivo, just as predicted by in vitro studies measuring UBE3A activity in the presence of
HERC2 or the HERC2 RLD2 domain (Kuhnle, Kogel et al. 2011). In measures of ASDlike behavior, simultaneous overexpression of both Dube3a and HERC2 increased social
spacing, while overexpression of HERC2 alone increased the amount of time flies spent
grooming. Simultaneous overexpression of Dube3a and HERC2 altered synaptic
morphology at the NMJ, and overexpression of both genes in PDF+ neurons in the
Drosophila brain altered the freerunning period in circadian rhythm analysis. Taken
together, these data suggest a complex interplay and synergistic interactions in vivo
between UBE3A and HERC2 in generating Dup15q phenotypes.
Our finding that elevated HERC2 reduces Dube3a levels are consistent with
experiments in in vitro studies in which HERC2 physically interacts with and stimulates
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Figure 3-5. Simultaneous HERC2 and Dube3a overexpression impairs circadian
rhythms.
A) Average activity plots (n ≥ 4 per genotype) of control flies (PDF-GAL4) or flies
overexpressing Dube3a (PDF>Dube3a), HERC2 (PDF>HERC2), or both HERC2 and
Dube3a (PDF>HERC2+Dube3a) in PDF+ neurons. Black horizontal bars indicate
periods of darkness. Lights cycled on/off on a 12-hour period for 3 days, followed by 7
days of complete darkness. B) Period length analysis for average activity across each
genotype in light/dark cycles and dark/dark cycles. In PDF>HERC2+Dube3a,
periodicity was completely abolished during the dark/dark period.
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the ubiquitin ligase activity of UBE3A (Kuhnle, Kogel et al. 2011). In both
c155>HERC2 and c155>HERC2+Dube3a compared to their respective controls we
observed reduced levels of Dube3a protein, suggesting increased autoubiquitination of
Dube3a through elevated HERC2 levels. HERC2 consists of multiple protein domains,
yet the RLD2 domain specifically is responsible for binding to and stimulating UBE3A,
and increased activity of UBE3A is independent of the catalytic HECT domain of
HERC2 (Kuhnle, Kogel et al. 2011). Human and Drosophila HERC2 proteins share a
high degree of sequence conservation, especially within the RLD2 domain. While it is
unlikely that the HECT domain of HERC2 is contributing to the increase in Dube3a
activity, further experiments, such as expressing only the RLD2 domain of Drosophila
HERC2 protein, should be conducted to establish that the in vitro activity paradigm holds
in vivo under multiple conditions.
The NMJ morphology defects that we observed upon simultaneous
overexpression of Dube3a and HERC2 are consistent with other studies using the
Drosophila NMJ to identify causal genes in ASD-associated CNVs. For example, in cases
of de novo CNV loss of chromosome 3 dlg and pak double mutants (fly orthologs to
genes located in the chromosome 3 CNV) displayed alterations in NMJ morphology,
while single mutants displayed no NMJ phenotype (Grice, Liu et al. 2015). Copy number
loss or gain of 16p11.2, a region containing approximately 30 genes, consistently
generates an ASD phenotype and may account for up to 1% of ASD cases (Marshall,
Noor et al. 2008, Weiss, Shen et al. 2008), and CNVs that impact multiple genes are
estimated to be found in up to 10% of the ASD population (Shishido, Aleksic et al.
2014). Sequencing known ASD genes from individuals in the Autism Clinical and
Genetic Resources in China (ACGC) revealed that individuals carrying multiple de novo
mutations in known ASD genes had more severe ASD phenotypes while parents carrying
only a single variant were relatively unaffected (Guo, Wang et al. 2018). Our data fits
into the two-hit, multifactorial model of ASD where altered function or expression of
multiple genes confer increased ASD risk.
Consistent with previous reports, data presented here indicate that Dube3a is a
regulator of Drosophila circadian rhythms. UBE3A ubiquitinates the key clock protein
BMAL1 (cycle in Drosophila), and overexpression of Dube3a in PDF+ neurons caused
impaired rhythms during dark/dark cycles in previous studies (Gossan, Zhang et al.
2014). In our experiments PDF>Dube3a flies remained rhythmic, however period length
was altered. It is possible that our line expressed Dube3a at lower levels, resulting in a
reduced phenotype. In line with the hypothesis that HERC2 protein stimulates the
ubiquitin ligase function of Dube3a, we observed a complete lack of rhythmicity in
PDF>HERC2+Dube3a flies indicating that HERC2 stimulates Dube3a activity. Sleep
disturbances have been reported in Dup15q, particularly in cases of interstitial
duplications (Urraca, Cleary et al. 2013), and our data implies that the interaction
between UBE3A and HERC2 may underlie this aspect of Dup15q.
In conclusion, we used biochemical and behavioral assays to probe the interaction
between Dube3a and HERC2 in vivo for the first time. We found that in some instances
HERC2 elevation is the predominant driver of the observed phenotype, yet in other
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instances the synergistic interaction between HERC2 and Dube3a resulted in the
phenotype. Our results highlight the use of Drosophila for investigating how multiple
genes within a CNV may be contributing to disease pathology and suggest that the
interaction between UBE3A and HERC2 is important in generating the phenotypes
associated with Dup15q syndrome.
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CHAPTER 4. GLIAL OVEREXPRESSION OF DUBE3A CAUSES SEIZURES
AND SYNAPTIC IMPAIRMENTS IN DROSOPHILA CONCOMITANT WITH
DOWNREGULATION OF THE NA+/K+ PUMP ATP-ALPHA2
Introduction
Duplication 15q syndrome (Dup15q) is caused by either interstitial or isodicentric
duplications of the chromosomal region 15q11.2-q13 .1. Dup15q is characterized by
autism, developmental delay, mental retardation, hypotonia, and epilepsy. The most
devastating feature of Dup15q is difficult to control seizures (Finucane, Lusk et al. 2016).
Approximately 65% of isodicentric Dup15q individuals have seizures that often begin as
infantile spasms that progress to Lennox-Gastaut type syndrome (Battaglia 2008,
Finucane, Lusk et al. 2016). Poorly controlled epilepsy severely impacts the quality of
life of both affected individuals and their caregivers. Current treatment options for
Dup15q-associated epilepsy are often ineffective. GABAergic promoting antiepileptics
are typically ineffective while broad-spectrum antiepileptic medications such as valproic
acid and rufinamide provide some relief (Conant, Finucane et al. 2014). Elevated levels
of UBE3A in neurons or duplication of a cluster of GABA receptors (GABRA5, GABRB3,
and GABRG3) located within Chr 15q11.2-q13.1 have been proposed as the etiology of
Dup15q epilepsy, although 15q copy numbers do not correlate with GABA receptor
transcript levels (Scoles, Urraca et al. 2011), and there is no robust experimental proof
connecting increased expression of GABA receptors to seizure susceptibility.
Multiple mouse models have been generated to investigate Dup15q pathobiology,
yet no model has recapitulated the seizure phenotypes observed in Dup15q individuals.
Mice harboring a 6.3 Mb duplication of Chr 7 (syntenic to the 15q11.2-q13.1 region in
humans) displayed social abnormalities and behavioral inflexibility when duplications
were paternally inherited (Nakatani, Tamada et al. 2009), although Dup15q syndrome
results primarily from maternally inherited duplications. Another mouse model
duplicating only Ube3a recapitulated deficits in social interaction, social communication,
and increased repetitive behavior but it is likely that the addition of a 3xFLAG tag to the
C-terminus of Ube3a rendered the ubiquitin ligase activity of Ube3a-FLAG protein nonfunctional (Smith, Zhou et al. 2011). More recently, overexpression of Ube3a limited to
neurons was not associated with seizures in mice but was linked to seizure-induced
decreased sociability (Krishnan, Stoppel et al. 2017). Elevated levels of Ube3a in
excitatory neurons in mice caused increased anxiety-like behaviors, cognitive
impairments, and reduced seizure threshold to pharmacologically induced seizures with
pentylenetetrazol, however spontaneous seizures have not been observed in these mice
(Copping, Christian et al. 2017). In summary, mouse models of Dup15q which focus on
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neuronal overexpression of Ube3a have failed to recapitulate the spontaneous Dup15q
seizure phenotype.
In contrast to neurons, glial cells biallelically express Ube3a (Yamasaki, Joh et al.
2003, Dindot, Antalffy et al. 2008, Judson, Sosa-Pagan et al. 2014, Grier, Carson et al.
2015). Analysis of post-mortem brain tissue from Dup15q individuals found elevated
levels of UBE3A transcript and protein (Scoles, Urraca et al. 2011). Even though glia
play a key role in epileptogenesis through regulation of ion homeostasis (Chvatal and
Sykova 2000, D'Ambrosio 2004, Devinsky, Vezzani et al. 2013), the functional
consequence of increased glial UBE3A has been unexplored in Dup15q syndrome. Due
to the absence of seizures in Dup15q mouse models, which have primarily focused on
elevating Ube3a expression in neurons, we hypothesized that increased glial expression
of UBE3A may contribute to the pathogenesis of epilepsy in Dup15q syndrome.
A related neurogenetic disorder, Angelman syndrome (AS), is also characterized
by a high rate of epilepsy (Williams, Beaudet et al. 2006, Thibert, Conant et al. 2009). AS
is caused by reciprocal deletions of the maternal 15q11.2-q13.1 region, methylation
defects, or loss-of-function point mutations which result in non-functional UBE3A
(LaSalle, Reiter et al. 2015). Due to the well-established link between UBE3A loss and
seizures in AS, we predict that UBE3A may similarly underlie seizures in Dup15q.
The primary role of UBE3A, an E3 ubiquitin ligase, is to transfer ubiquitin
moieties from an E2 ligase to substrate proteins, targeting them for degradation by the
ubiquitin proteasome system (Finley 2009, Zheng and Shabek 2017). Several
investigative teams, including our own, have long been searching for UBE3A substrates
relevant to Dup15q and AS phenotypes. However, due to the transient nature of the
interaction between an E3 ubiquitin ligase and its substrate proteins, only a handful of
confirmed UBE3A substrates have emerged thus far (LaSalle, Reiter et al. 2015). As a
result of the limited number of UBE3A substrates currently identified, the molecular
mechanism of seizure production in Dup15q (and AS) individuals remains largely
unknown.
Our laboratory previously used the genetically tractable model organism
Drosophila melanogaster to identify Dube3a (the fly homolog of UBE3A) substrates in
whole head fly extract following a transient elevation of Dube3a levels in all cell types
(Jensen, Farook et al. 2013). We identified approximately 50 proteins whose expression
was altered by increased Dube3a expression. One of these proteins was the
sodium/potassium (Na+/K+) exchanger ATPα, and we confirmed that ATPα is
ubiquitinated in a Dube3a-dependent manner in vitro (Jensen, Farook et al. 2013). Prior
work demonstrated that Drosophila with reduced levels of ATPα protein display a bangsensitive seizure phenotype (Schubiger, Feng et al. 1994, Sun, Xu et al. 2001, Palladino,
Bower et al. 2003). Glial specific knockdown of the β subunit of the Na+/K+ pump nrv2
also results in seizure-like behaviors (Ng, Sengupta et al. 2016), thereby supporting the
idea that impaired glial-dependent regulation of extracellular ion concentration
contributes to the pathogenesis of seizures. Na+/K+ homeostasis is critically important for
proper central nervous system function, while perturbation of Na+/K+ balance has been
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identified as an underlying cause of epilepsy in humans (Somjen 2002, Scharfman 2007).
Here, we follow up on the consequences of the interaction between Dube3a and ATPα in
an attempt to understand the underlying mechanism of seizures in our novel fly model of
Dup15q epilepsy.
Methods
Fly Stocks
All flies were maintained at 25°C on a 12-hour light/dark cycle and raised on
standard corn meal media (Bloomington Drosophila Stock Center). The following stocks
were obtained from the Bloomington Drosophila Stock Center (Bloomington, IN): UASATPα-RNAi (BDSC# 32913), 10XUAS-IVS-myr::tdTomato (referred to as UAStdTomato, BDSC#32222) and repo-GAL4 (BDSC# 7415). The ATPα::GFP reporter line
was generated by the FlyTRAP project (Morin, Daneman et al. 2001), and the UASATPα line was obtained from FlyORF (Bischof, Bjorklund et al. 2013). The following
Dube3a and UBE3A lines were used in this study and described previously (Reiter,
Seagroves et al. 2006): UAS-Dube3a, UAS-Dube3aC/A, and UAS-UBE3A. elav-GAL4
was provided by Dr. Hugo Bellen and UAS-GFP was provided by Dr. Cynthia Hughes.
Quantitative Western Blot Analysis
30-40 fly heads were removed and homogenized in RIPA buffer containing
complete protease inhibitor cocktail (Roche). Samples were spun at 9,500 x g for 1
minute to remove debris and the supernatant containing protein was used for analysis.
Samples were resolved by loading 20 μg of protein into each lane of a 1.5 mm NuPAGE
Bis-Tris 4-12% gradient gel (Invitrogen) and transferred to Immobilon-FL PVDF
membrane (Millipore). Membranes were blocked with 5% bovine serum albumin, 3%
milk, and 0.1% Tween-20 in phosphate buffered saline (PBS). Primary antibodies used
were α-GAPDH (1:5000, IMGENEX Cat# IMG-3073), α-ATPα (1:5000, Developmental
Studies Hybridoma Bank Cat# A5-S) and α-ELAV (1:200, Developmental Studies
Hybridoma Bank Cat# 7E8A10). α-goat (LI-COR Cat# 925-68074), α-rat (LI-COR Cat#
926-68076), and α-mouse (LI-COR Cat# 926-32212) infrared secondary antibodies were
used at 1:7500. The blot was imaged using the Odyssey Infrared Imaging System (LiCor) and all lanes were normalized to a GAPDH loading control as the reference for
calculating adjusted relative signal intensities.
Immunohistochemistry and Image Acquisition
Flies were briefly anesthetized with CO2, heads were removed and submerged in
a dissecting dish containing PBS. Brains were dissected and fixed in 4% formaldehyde
for 1 hour. Following 3 washes for 5 minutes in PBS, brains were blocked and
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permeabilized with 5% bovine serum albumin and 0.1% Triton X-100. Primary
antibodies used in this study were mouse α-repo (Developmental Studies Hybridoma
Bank Cat# 8D12, 1:100), mouse α-brp (Developmental Studies Hybridoma Bank Cat#
NC82, 1:100), rat α-Dube3a (Gift from Dr. Janice Fischer, 1:100), mouse α-FasII
(Developmental Studies Hybridoma Bank Cat# 1D4, 1:100), and rabbit α-GFP (Abcam
Cat# ab6556, 1:1000). Secondary antibodies used were AlexaFluor 594 goat α-mouse
secondary antibody (ThermoFisher Cat# A11005, 1:500), AlexaFluor 488 goat α-rat
(ThermoFisher Cat# A11006, 1:500), and AlexaFluor 488 goat α-rabbit (ThermoFisher
Cat# A11008, 1:500). Slides were mounted with Vectashield mounting medium (Vector
Labs Cat# H-1200).
Images were captured on a Zeiss 710 confocal microscope (Zeiss) in the UTHSC
Neuroscience Institute Imaging Core at 1024 x 1024 resolution with a 63X objective,
numerical aperture 1.4. Z-sections were acquired at 1 μm optical section thickness.
Detector gain and offset were optimized to the control group and were not changed
between brains once the configuration was set to allow for direct comparisons. Images
were acquired with ZEN Software (Zeiss).
Co-localization Analysis
Co-localization analysis was performed using the ImageJ plugin Coloc 2
(Schneider, Rasband et al. 2012). A 50 μM x 50 μM section was selected from
ATPα::GFP brains stained with α-GFP and α-Dube3a antibodies for analysis.
Seizure Susceptibility Assays
For all behavioral tests, flies were not exposed to CO2 for at least two days prior
to testing. BSA was performed as previously described (Benzer 1971, Ganetzky and Wu
1982, Stone, Burke et al. 2014). Flies were transferred via mouth pipette to empty
standard fly vials and subjected to mechanical stress (“bang”) by vortexing the vial on a
standard laboratory vortexer (LabNet) at top speed for 10 seconds. At the end of the
“bang”, a timer was started and the duration of paralysis and uncontrolled movements
was recorded. Flies were considered “recovered” when they righted themselves and were
able to walk or groom.
For heat induced paralysis assays, flies were transferred to empty plastic fly vials
and the vials were submerged in a 39°C water bath. The number of immobile flies was
recorded in 30-s intervals and the assay continued for a total of 6 min.
For photogenic-induced paralysis, flies were transferred to empty plastic fly vials
and placed in a dark room for 30 min prior to testing. Vials were placed 5 cm from a
strobe light (C4162 High Power Strobe, Chaney Electronics) and subjected to 10 Hz
stimulation for 10 s. Recovery time was recorded and was defined by the same
parameters as for BSA.
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Chemical Inhibition of ATPα Function
Flies were fed ouabain (Sigma, 03125) using a previously described method (Sun,
Xu et al. 2001). Briefly, three-day old flies were fed 10 mM ouabain dissolved in water
containing 5% sucrose for three hours by placing flies in an empty vial with containing a
Kimwipe saturated with ouabain solution. Green food coloring (1%) was included in the
feeding solution to ensure flies consumed the ouabain solution, as indicated by their
abdomens turning green. Following three hours of feeding, flies were tested for seizure
susceptibility in the BSA.
Glial Cell K+ Content Assay
Stock solutions of 1 mM Asante Potassium Green 2 (APG-2, TEFlabs, a
fluorescent cell membrane permeable K+ indicator) were prepared in DMSO. Three-day
old repo>tdTomato or repo>Dube3a+tdTomato flies were briefly anesthetized with CO2
and their heads were removed and submerged in room temperature Drosophila saline
consisting of the following (in mM): 128 NaCl, 1.8 CaCl2, 2 KCl, 5 MgCl2, 36 sucrose,
5 HEPES, pH 7.2. Brains were dissected from the head case and incubated with 7.5 µM
APG-2 in Drosophila saline at room temperature with gentle agitation for 1 hour. Brains
were washed 2X with Drosophila saline and wet mounted on a microscope slide with
Drosophila saline.
Images were captured from the optic lobe on a Leica DM6000B microscope
(Leica) using a 63X oil immersion lens using the N3 and L5 filters for tdTomato and
APG-2 respectively. Exposure times were calibrated on repo>tdTomato brains and
microscope settings remained constant between repo>tdTomato and
repo>Dube3a+tdTomato groups to allow for direct comparison of fluorescence intensity.
APG-2 fluorescence intensity was calculated offline using ImageJ (Schneider, Rasband et
al. 2012). The APG-2 channel was converted to 8-bit greyscale, and tdTomato-positive
glial cells were selected for analysis. Cells were selected using the “freeform” tool to
outline the cell body in the APG-2 channel. Using the “measure” command, the mean
fluorescence value for each cell was recorded. A total of 40 cells was analyzed per group
from at least 3 images per group and 3 brains per group.
Electroretinogram Analysis
Electroretinograms (ERGs) were performed as previously described (Hope,
LeDoux et al. 2016). Briefly, custom-made tungsten wire electrodes were gently inserted
into the right eye (recording) and abdomen (ground) of immobilized flies. Fly eyes were
stimulated using 1-sec light pulses from a 5-mm LED (RadioShack). Data was collected
with a Model 1800 Microelectrode AC Amplifier (A-M Systems), digitized with a

39

Micro3 1401 digitizer (Cambridge Electronic Design), and analyzed with Spike2
software (Cambridge Electronic Design).
Electron Microscopy
Fly heads were dissected and fixed in 2.5% glutaraldehyde solution overnight at
4°C. Fixed heads were processed, resin embedded, and sectioned (50 nm) by the UTHSC
Neuroscience Institute Core. A JEM-2000EXII microscope (JEOL USA, Inc.) at 60 kV
was used to capture transmission electron microscopy images at 10,000X.
Statistical Analysis
All statistical tests were performed using Prism version 6.0 (GraphPad). To test
for statistical significance of two samples, Student’s t-test was used. To determine
statistical significance among multiple samples, we used a one-way ANOVA with
Tukey’s multiple comparisons. An alpha (α) of 0.05 was chosen for statistical
significance.
Results
Glia Endogenously Express both Dube3a and ATPα Proteins
Dube3a is expressed broadly in neurons of the fly larval and adult brain (Wu,
Bolduc et al. 2008). Our laboratory recently demonstrated that Dube3a is not subjected to
the complex imprinting observed in mammals and is biallelically expressed in fly heads
(Hope, LeDoux et al. 2016). UBE3A is known to be expressed solely from the maternal
allele in mature mammalian neurons and biallelically expressed in mammalian glial cells
(Yamasaki, Joh et al. 2003, Dindot, Antalffy et al. 2008, Judson, Sosa-Pagan et al. 2014,
Grier, Carson et al. 2015). To determine if glial cells express Dube3a, we performed
immunohistochemistry for the glial-specific transcription factor reversed polarity (Repo)
and Dube3a in wildtype adult fly brains. We observed co-localization of Repo and
Dube3a signals indicating that glial cells endogenously express Dube3a (Figure 4-1A).
Our laboratory previously found that the Na+/K+ pump ATPα is ubiquitinated in a
Dube3a-dependent manner using an in vitro ubiquitination assay (Jensen, Farook et al.
2013). For Dube3a to ubiquitinate ATPα in vivo, the two proteins must be present in the
same cell. Therefore, we performed immunohistochemistry on brains from ATPα::GFP
flies with antibodies against both GFP and Dube3a to determine if ATPα and Dube3a
proteins co-localize in vivo. We observed a lattice-like staining pattern of ATPα::GFP in
the optic lobes and relatively similar, yet more diffuse Dube3a staining patterns which
overlapped with ATPα::GFP in several regions of the brain (Figure 4-1B, C).
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Figure 4-1. Glia endogenously express Dube3a and overexpression of Dube3a
reduced ATPα protein levels in the brain.
A) Wild type adult fly brains stained for the glial specific transcription factor repo and E3
ubiquitin ligase Dube3a reveals a strong co-localization of the two signals, and
Drosophila glia endogenously express Dube3a. B) and C) Immunohistochemistry of
adult wild type fly brains for ATPα and Dube3a revealed that Dube3a and ATPα colocalize. Cellular co-localization of the two proteins indicates the potential for Dube3a to
directly ubiquitinate ATPα in vivo. Scale bar is 20 micrometers (Image C is a zoomed
region indicated by the box in B). D) Western blot for ATPα levels from control (UASDube3a), neuronal overexpression (elav>Dube3a), or glial overexpression
(repo>Dube3a) fly heads. E) Quantification of signals from D) indicate a significant
decrease in ATPα levels in the brain. Note that Dube3a levels from repo>Dube3a are
reduced by greater than 50%. A one-way ANOVA revealed a significant effect of
genotype on ATPα levels (p ≤ 0.001). Tukey’s multiple comparisons test (α = 0.05)
indicated reduced levels of ATPα in elav>Dube3a compared to UAS-Dube3a (p ≤ 0.05)
and also in repo>Dube3a compared to UAS-Dube3a (p ≤ 0.001). n = 3 for all samples,
and data are presented as mean ± SEM.
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Quantitative co-localization analysis indicated strong overlap of ATPα and Dube3a
proteins (r = 0.78, Figure 4-2). These data suggest that ATPα and Dube3a are present in
at least some of the same cells in adult fly brain.
To determine whether Dube3a is able to regulate ATPα in vivo, we utilized the
GAL4/UAS system (Brand and Perrimon 1993) to overexpress Dube3a in either neurons
with elav-GAL4 or glia with repo-GAL4. We compared ATPα levels from fly heads via
western blot from control UAS-Dube3a alone, elav>Dube3a, and repo>Dube3a animals
(Figure 4-1D). There was a significant overall effect of genotype on ATPα levels
(Figure 4-1E, One-way ANOVA, P < 0.001). Post-hoc comparisons indicated that ATPα
levels were significantly reduced in elav>Dube3a compared to UAS-Dube3a alone (P <
0.05) and in repo>Dube3a compared to UAS-Dube3a alone (P < 0.001). These results
are consistent with our previous studies indicating that Dube3a can regulate ATPα levels
in the brain in a ubiquitin dependent manner.
Overexpression of Dube3a in Glia Using repo-GAL4 Results in Seizure
Susceptibility
During our repo>Dube3a experiments, we serendipitously observed a bangsensitive phenotype in repo>Dube3a flies. To quantify this observation, we performed a
series of seizure assays in both repo>Dube3a and elav>Dube3a animals. Utilizing the
well-characterized bang sensitivity assay (BSA) (Benzer 1971, Ganetzky and Wu 1982,
Stone, Burke et al. 2014), we subjected flies to mechanical stress and measured time to
recovery. Control repo-GAL4 alone or neuronal overexpression elav>Dube3a flies did
not display a bang-sensitive phenotype, whereas glial Dube3a overexpression with
repo>Dube3a resulted in robust bang-induced paralysis (Figure 4-3A). We did not
observe bang-sensitivity when we expressed catalytically-inactive ligase-dead Dube3a in
glia using repo>Dube3aC/A (Figure 4-3A), indicating that bang sensitivity requires the
ubiquitin ligase activity of Dube3a. Additionally, we observed both heat-induced and
photogenic paralysis in repo>Dube3a animals (Figure 4-4A, B), indicating that seizures
may be initiated by multiple modalities in repo>Dube3a flies.
To evaluate the developmental time course of seizure susceptibility in
repo>Dube3a we measured bang-sensitivity at 0-2 days, 3-6 days, and 7-10 days posteclosion. We found that approximately 50% of repo>Dube3a flies were bang-sensitive at
0-2 days post-eclosion and by 3-6 days all repo>Dube3a flies showed bang-sensitivity.
By 7-10 days, no repo>Dube3a flies recovered from the bang within the 2-min assay
period (Figure 4-3B). These results indicate that seizures develop over time in adult flies
overexpressing Dube3a in glia.
Because fly Dube3a and human UBE3A are greater than 70% identical in the Cterminal HECT domain but display less conservation in the N-terminus (Reiter,
Seagroves et al. 2006), we next wanted to determine if overexpression of human UBE3A
in fly glia also resulted in seizure susceptibility. In repo>UBE3A flies, we observed a
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Figure 4-2. Co-localization analysis results from Dube3a and ATPα signals in the
fly optic lobe.
Analysis generated from images in Figure 3-1C using the ImageJ plugin Coloc 2.
Channel 1 represents the Dube3a image channel converted to greyscale and channel 2
represents ATPα. 2D intensity histogram represents the correlation of pixels across the
two images.
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Figure 4-3. Elevated levels of Dube3a in glia result in seizure susceptibility in the
bang-sensitivity seizure assay.
A) 3–5 day old flies from each genotype were tested in the BSA. Control (repo-GAL4, n
= 15), overexpression of ligase dead Dube3a in glia (repo>Dube3aC/A, n = 10), neuronal
overexpression of Dube3a (elav>Dube3a, n = 12), had no effect on seizure susceptibility
(100% recovery at 10 seconds). Only overexpression of Dube3a in glia with
repo>Dube3a (n = 18) caused bang sensitivity (80% recovery at 120 seconds).
B) Seizures in repo>Dube3a flies progressively worsened as flies aged. Control repoGAL4 flies did not display seizure activity at 0–2 days (n = 20), 3–6 days (n = 24), or 7–
10 days (n = 24) of age (100% recovery at 10 seconds). Approximately 50% of
repo>Dube3a flies display seizures at 0–2 days (n = 17), 100% of repo>Dube3a flies
had seizures at 3–6 days (n = 22) and recovered steadily over 2 minutes, and all
repo>Dube3a flies at 7–10 days (n = 4) had immediate seizure-like activity after BSA
leading to paralysis and death (note the 3–6 day time point includes data from 2A). C)
Overexpression of human UBE3A in glia with repo>UBE3A resulted in a similar, but less
severe, seizure phenotype. At 0–2 days (n = 27), repo>UBE3A flies displayed little
seizure activity. However, by 3–6 (n = 39) and 7–10 (n = 34) days, repo>UBE3A flies
displayed seizures similar to that of 3–6 day old repo>Dube3a flies.
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Figure 4-4. Seizures can be induced by heat or light in repo>Dube3a animals.
A) 3–5 day old flies were tested for heat-induced paralysis by elevating ambient
temperature to 39°C. This treatment had no effect on repo-GAL4 alone flies (blue line, n
= 25), however in repo>Dube3a animals (red line, n = 12) all animals were paralyzed
within 1 minute. We observed moderate heat-induced paralysis in repo>UBE3A flies
(purple line, n = 20), and a minimal effect in elav>Dube3a animals (black line, n = 36).
We observed no heat-induced paralysis when catalytically inactive Dube3a was
expressed in glial cells with repo>Dube3aC/A (orange line, n = 25) flies. B) Photogenic
stimulation had no effect on repo-GAL4 alone flies (blue line, n = 22), elav>Dube3a
(black line, n = 26), or in ligase dead repo>Dube3aC/A flies (orange line, n = 23).
Photogenic paralysis was observed in approximately 40% of repo>Dube3a animals (red
line, n = 27), however repo>UBE3A animals were not susceptible to photogenic-induced
paralysis (purple line, n = 28).
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similar but less severe bang-sensitivity that progressively worsened as flies aged just as
repo>Dube3a seizure severity progressively worsened in adult animals (Figure 4-3C).
Moreover, repo>UBE3A flies also demonstrated heat-induced paralysis, although heatsensitivity was less severe than in repo>Dube3a animals (Figure 4-4A). These
experiments demonstrate that human UBE3A can emulate fly Dube3a in our Dup15q
model implying shared substrate specificity between flies and humans for this E3
ubiquitin ligase.
Next, we capitalized on the temperature dependence of GAL4-driven transgene
expression levels to investigate whether overexpression of Dube3a in early development
or adulthood causes seizures (Figure 4-5A). Temperatures of 18°C reduce transgene
expression, while 25°C induces transgene expression. Raising repo>Dube3a flies at 18°C
(repo>Dube3a 18-18) from early embryonic stages through adulthood completely
suppressed the seizure phenotype, as did raising repo>Dube3a flies at 18°C during the
embryo, larval, and pupal stages and then shifting to 25°C for five days before testing for
seizures (Figure 4-5B, repo>Dube3a 18-25). However, repo>Dube3a flies raised at
25°C and overexpressing Dube3a in the embryo, larval, and pupal stages before reducing
Dube3a expression in adulthood by shifting to 18°C on the day on the day of eclosion
(repo>Dube3a 25-18) displayed bang-sensitive seizures at 5 days of age (Figure 4-5B).
These data suggest that overexpression of Dube3a in glia early in development is critical
for the development of the seizure phenotype and initiates a seizure prone system that
cannot be rescued by simply reducing Dube3a levels in adulthood.
Genetic and Pharmacologic Manipulation of ATPα Modifies Seizure Susceptibility
In order to establish that Dube3a mediated degradation of ATPα is the primary
cause of seizures, we investigated ATPα protein stability and abundance in the brain
under various conditions. We performed quantitative western blot analysis of ATPα
levels in flies overexpressing human UBE3A in glial cells to determine if ATPα is
downregulated by human UBE3A protein, and on flies co-overexpressing ATPα on a
repo>Dube3a background to determine whether downregulation of ATPα could be
genetically rescued (Figure 4-6A). There was a marked effect of genotype (Figure 4-6B,
One-way ANOVA, P < 0.0001) but no significant differences between control repoGAL4 alone and ligase-dead overexpression repo>Dube3aC/A, indicating the
downregulation of ATPα is dependent upon the ubiquitin ligase activity of Dube3a.
Again, we observed significant downregulation of ATPα in repo>Dube3a animals (P <
0.01), similar to our earlier results (Figure 4-1D, E). No significant differences were
observed in ATPα levels between control and ATPα overexpression animals
(repo>Dube3a+ATPα) indicating that ATPα can be restored to near normal protein
levels by simultaneously overexpressing ATPα in repo>Dube3a flies (Figure 4-6A, B).
Overexpression of human UBE3A in repo>UBE3A flies resulted in a similar
downregulation of ATPα (Figure 4-6A, B, P < 0.001) again suggesting conserved
ubiquitin ligase substrates between fly Dube3a and human UBE3A.
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Figure 4-5. Glial Dube3a overexpression in early development, but not adulthood,
causes bang-sensitive seizures.
A) Schematic for the temperature shifts to induce/repress Dube3a overexpression.
Repo>Dube3a 18-18 flies were raised at 18°C throughout development and adulthood.
Repo>Dube3a 18-25 flies were raised at 18°C throughout development and shifted to
25C to induce Dube3a overexpression in adulthood. Repo>Dube3a 25-18 flies were
raised at 25°C (Dube3a overexpression during development) which was then turned off
in adulthood by shifting to 18°C on the day of eclosion. All flies were tested for seizures
at 5 days of age. B) Average recovery time in the bang sensitivity assay. Only
repo>Dube3a 25-18 displayed bang-sensitive seizures (One-way ANOVA, p ≤ 0.0001, n
≥ 8 per genotype), indicating that overexpression of Dube3a in glia during development
results in a seizure phenotype, but expression post eclosure alone does not cause seizures.
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Figure 4-6. Genetic or pharmacologic manipulation of ATPα modulates seizure
severity.
A) and B) We observed a significant effect of genotype on ATPα protein levels (OneWay ANOVA, p ≤ 0.0001). ATPα protein levels are partially restored in repo>Dube3a
flies by concurrent overexpression of ATPα (p = 0.30). We observed no reduction in
ATPα when we overexpressed catalytically inactive Dube3a in glial cells (p = 0.09), but
overexpression of human UBE3A in glia similarly resulted in reduced levels of ATPα (p
≤ 0.0001). n ≥ 3 for all blots. C) Overexpression of ATPα in repo>Dube3a animals
rescues seizure susceptibility (p ≤ 0.005, n ≥ 14 all groups). D) Feeding repo>Dube3a
flies the Na+/K+ pump inhibitor ouabain increases seizure severity (p ≤ 0.01, n ≥ 9 for all
groups) likely due to the reduced levels of ATPα. E) Glial specific knockdown of ATPα
results in seizure susceptibility (p ≤ 0.005, n ≥ 14 all groups). Data are presented as mean
± SEM.
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We next performed BSA on repo>Dube3a+ATPα flies to determine if restoring
ATPα levels specifically within glial cells of repo>Dube3a animals was capable of
rescuing seizure behavior. Compared to repo>Dube3a flies, repo>Dube3a+ATPα
animals had significantly reduced seizure severity as indicated by reduced seizure time on
the BSA (Figure 4-6C, t-test, P < 0.005). Therefore, reduced ATPα protein levels are
necessary for seizure susceptibility in repo>Dube3a flies.
The cardiotonic steroid ouabain is a known allosteric inhibitor of the Na+/K+
pump function of ATPα. We predicted that repo>Dube3a animals with reduced ATPα
levels would be more susceptible to chemical ATPα inhibition and display longer
recovery times on the BSA. We fed flies 10 mM ouabain for 3 hours (a dose low enough
to have no effect on control flies) and performed BSA (Figure 4-6D, t-test, P ≥ 0.05). In
repo>Dube3a animals there was a significant increase in recovery time on the BSA
(Figure 4-6D, t-test, P < 0.005). These experiments confirm the connection between
seizure susceptibility and ATPα function.
If Dube3a-dependent reduction in ATPα is responsible for seizures in
repo>Dube3a flies, then glial-specific knockdown of ATPα should also result in seizure
susceptibility. Loss-of-function ATPα mutants are known to show seizure susceptibility,
but these mutants have reduced ATPα throughout all tissues in the body (Schubiger, Feng
et al. 1994). To determine if glial-specific knock down of ATPα is sufficient to cause
seizures, we crossed repo-GAL4 flies to UAS-ATPα-RNAi flies and performed the BSA.
We observed significantly increased recovery times in repo>ATPα-RNAi flies compared
to controls (Figure 4-6E, t-test, P < 0.005), showing that glial-specific reduction of
ATPα levels is sufficient to generate a seizure phenotype, albeit less severe than that
found in repo>Dube3a animals. This also implies that additional Dube3a glial substrates
may contribute to the seizure phenotype.
Glial Dube3a Overexpression Alters Neuronal Architecture
We examined the mushroom body (MB) in adult flies to investigate the
morphological effects of glial Dube3a overexpression. Immunohistochemistry was
performed with an α-FasII antibody in repo>GFP and repo>GFP+Dube3a animals. The
α lobe of the mushroom body normally extends dorsally in a single column and the γ lobe
displays FasII immunoreactivity as seen in control repo>GFP brains (Figure 4-7A, top
row). In the MB of repo>GFP+Dube3a flies we observed a loss of FasII immunereactivity in the γ lobe and a misdirected portion of the α lobe (Figure 4-7A, bottom row,
arrows). These results indicate that elevated levels of Dube3a in glia disrupt proper
formation of the MB.
To further investigate neuronal architecture in glial Dube3a overexpression
animals we stained adult fly brains with α-brp antibody to visualize synaptic organization
(Wagh, Rasse et al. 2006). The optic lobe (OL) of Drosophila displays a laminar structure
with the outer medulla (OMe) and inner medulla (IMe) separated by a column of glial
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Figure 4-7. Overexpression of Dube3a in glia alters mushroom body and optic
lobe morphology.
A) Adult repo>GFP or repo>GFP+Dube3a fly brains stained with α-FasII antibody to
visualize the mushroom body (MB). In repo>GFP animals (top row), α-FasII marks α, β,
and γ lobes, with the α lobe making a single dorsal projection. In repo>GFP+Dube3a
(bottom row) flies we observed a loss of α-FasII immunoreactivity in the γ lobe (dashed
circle) and a portion of the α lobe was misdirected (arrows). B) Adult repo>GFP or
repo>GFP+Dube3a fly brains stained with α-Brp antibody to visualize neuronal
organization in the optic lobe. In repo>GFP animals (top row), α-Brp reveals the laminar
organization of the optic lobe consisting of the outer medulla (OMe), inner medulla
(IMe), and lobula plate (LP), with the IMe and LP separated by a band of GFP+ glial
cells. In repo>GFP+Dube3a animals (bottom row) the laminar structure of the optic lobe
is conserved, however Brp+ projections are observed in the glial cell layer between the
IMe and LP. Scale bar is 20 micrometers. C) and D) Western blot analysis of the
neuronal marker elav in fly heads revealed no change in repo>Dube3a (n = 3) vs. repoGAL4 (n = 3) alone brains (p = 0.42). Data are presented as mean ± SEM.
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cells from the lobular plate (LP) (Figure 4-7B, top row). Upon overexpression of Dube3a
in glia we observed a similar laminar structures in the OL of repo>GFP+Dube3a brains,
however α-brp immunoreactivity was observed in the GFP+ column of glial cells
separating the IMe from the LP which was not observed in control flies (Figure 4-7B,
bottom row, arrow). Again, these results indicate that overexpression of Dube3a in glial
cells results in abnormal development of neuroanatomical structures.
Western blot analysis of the neuronal-specific transcription factor embryonic
lethal abnormal vision (elav) was used to determine if reduced levels of ATPα in
repo>Dube3a flies was a consequence of reductions in the total number of fly neurons in
the fly brains. We did not observe a difference in elav protein levels between repo-GAL4
and repo>Dube3a animals (Figure 4-7C, D, t-test, P ≥ 0.05), suggesting that neuronal
loss is not the primary cause of seizures in repo>Dube3a flies.
Overexpression of Dube3a in Glia, but Not Neurons, Impairs Photoreceptor Neuron
Function
Seizures are thought to be primarily caused by excitatory/inhibitory imbalances in
neurons. Functional changes in neuronal activity due to changes in Dube3a have been
studied at the fly larval neuromuscular junction (Valdez, Scroggs et al. 2015), but
synaptic transmission defects caused by overexpression of Dube3a have not been
investigated in adult flies. Since seizures are caused by abnormal neuronal activity (Wu,
Liu et al. 2015), we next wanted to directly measure neuronal function in the fly.
Electroretinograms (ERGs) have long been used to measure synaptic activity and
photoreceptor neuron function in the fly eye (Ugur, Chen et al. 2016). Using ERGs, we
observed a significant effect of Dube3a or UBE3A overexpression in both “on” transients
(Figure 4-8A, B, One-way ANOVA, p < 0.0001) and “off” transients (Figure 4-8C,
One-way ANOVA, p < 0.0001), as well as photoreceptor potentials (Figure 4-8A, D,
One-way ANOVA, p < 0.0001). Tukey’s multiple comparison test (α = 0.05) indicated
no effect of neuronal overexpression of Dube3a in elav>Dube3a animals on any ERG
component, though there was a significant difference between repo>Dube3a and
repo>UBE3A compared to control repo-GAL4 alone flies in on/off transients and
photoreceptor potentials. Again, no differences were observed between repo>Dube3aC/A
in any ERG component (Figure 4-8A through D), indicating the effects of Dube3a
overexpression in glia are due to the ubiquitin ligase activity of Dube3a. Thus, Dube3a
overexpression in glia, but not neurons, causes downstream synaptic defects in neurons in
a cell non-autonomous manner.
To further investigate these ERG defects, we conducted an ultrastructural analysis
of the fly eye using transmission electron microscopy. Ommatidial cross-sections of
control repo-GAL4 and repo>Dube3a animals revealed that both groups had similar
stereotypic arrangements of photoreceptor neurons (Figure 4-9). In addition, secondary
pigment glial cells are present and directly contact photoreceptor neurons in both repo-
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Figure 4-8. Overexpression of Dube3a in glia alters ERG signals and reduces
internal K+ levels in glial cells.
A) Control repo-GAL4 alone (n = 10) ERGs display robust on/off transients and
photoreceptor potentials. Overexpression of Dube3a in neurons with elav>Dube3a, (n =
8) or overexpression of ligase dead Dube3a in glia (repo>Dube3aC/A, n=8) has no effect
on the ERG signal. However, ERGs of glial overexpression of Dube3a (repo>Dube3a, n
= 11) or human UBE3A (repo>UBE3A, n = 8) flies show reduced on/off transients and
reduced photoreceptor potentials in 3–5 day old flies. B) Quantification of on transients.
C) Quantification of photoreceptor potentials. D) Quantification of off transients. Data is
presented as mean ± SEM. E) Using the fluorescent K+ indicator Asante Potassium Green
2 (APG-2) and tdTomato to mark glial cells, we quantified internal potassium levels of
control (repo>tdTomato) and glial overexpression of Dube3a (repo>tdTomato+Dube3a)
glia. F) Quantification of the APG-2 fluorescence revealed a significant reduction in
fluorescence signal (p ≤ 0.01), indicating reduced intracellular K+ levels. Scale bar is 20
micrometers, and n = 40 cells from 3 flies per group. Data are presented as mean ± SEM.
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Figure 4-9. Transmission electron microscopy of control (repo-GAL4) or glial
Dube3a overexpression (repo>Dube3a) ommatidia of 5 day old flies.
Pigment cells (glia) surround and contact photoreceptor neurons in both repo-GAL4 and
repo>Dube3a (arrows), indicating ERG defects are not due to a failure of glial cells to
contact neurons. Scale bar is 2 micrometers.
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GAL4 and repo>Dube3a flies (Figure 4-9, arrows), indicating abnormal ERGs do not
arise from gross photoreceptor defects or a lack of physical interaction between
supporting glial cells and photoreceptor neurons.
Glial-specific Overexpression of Dube3a Causes Reduced Intercellular K+ in Glial
Cells
The function of ATPα is to pump K+ into the cell while pumping Na+ into the
extracellular space in an ATP-dependent manner. Since repo>Dube3a animals have
reduced levels of ATPα, we predicted that glial cells in the fly brain would have reduced
intracellular K+ concentrations. We dissected whole brains from repo>tdTomato or
repo>tdTomato+Dube3a animals to visualize glia and incubated them with the cellpermeant fluorescent K+ indicator Asante Potassium Green 2 AM (APG-2). We then
quantified the fluorescence of APG-2 in tdTomato-positive cells to determine the relative
concentration of K+ in repo>tdTomato and repo>tdTomato+Dube3a glial cells. We
observed a significant reduction in APG-2 fluorescence in repo>tdTomato+Dube3a
compared to control repo>tdTomato glial cells (Figure 4-8E, F, t-test, P < 0.01). These
data indicate that elevated Dube3a levels within glia reduce internal K+, consistent with
the hypothesis that Dube3a downregulates ATPα levels causing a disruption of Na+/K+
homeostasis.
Discussion
To date, animal models of Dup15q focused on neuronal overexpression of UBE3A
have failed to recapitulate the seizure phenotypes observed in Dup15q. Our fly model of
Dup15q with elevated levels of Dube3a in glia, but not neurons, displays a robust seizure
phenotype, highlighting the previously unappreciated role that glia play in Dup15q
pathophysiology. Our lab previously demonstrated that Dube3a is biallelically expressed
in the Drosophila brain (Hope, LeDoux et al. 2016), and here we demonstrate that
Drosophila glia endogenously express Dube3a in addition to expression in neurons.
Studies in mammalian systems have indicated biallelic expression of Ube3a/UBE3A in
glial cells (Yamasaki, Joh et al. 2003, Dindot, Antalffy et al. 2008, Judson, Sosa-Pagan et
al. 2014, Grier, Carson et al. 2015), yet until now the functional consequence of
overexpression of Ube3a/Dube3a in glial cells has been largely unexplored. Increased
dosage of the E3 ubiquitin ligase UBE3A is thought to be the underlying cause of at least
the autistic features of Dup15q syndrome (LaSalle, Reiter et al. 2015), and evidence
presented here suggests that elevated UBE3A contributes to epilepsy in Dup15q as well.
Drosophila harboring loss-of-function mutations in ATPα have previously shown
a bang-sensitive phenotype (Schubiger, Feng et al. 1994, Sun, Xu et al. 2001, Palladino,
Bower et al. 2003), and bang-sensitivity is a simple yet robust measure of seizure-like
activity in flies (Benzer 1971, Ganetzky and Wu 1982, Stone, Burke et al. 2014). Here we
utilized the GAL4/UAS system (Duffy 2002) to selectively knockdown ATPα levels in
glial cells. This approach revealed the importance of Na+/K+ regulation within glial cells
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on proper central nervous system function, as glial-specific knockdown of ATPα
generated a bang-sensitive seizure phenotype. Glial dysfunction is well-recognized as a
major contributor to epilepsy (Wetherington, Serrano et al. 2008, Devinsky, Vezzani et
al. 2013), and the data presented herein suggests that glial dysfunction contributes to the
pathogenesis of epilepsy in Dup15q.
One role of glial cells is to maintain ion homeostasis in the central nervous
system. Normally, K+ is pumped into glial cells via ATPα to maintain relatively low
concentrations of K+ in the extracellular space (Figure 4-10A). When Dube3a (or
UBE3A) is elevated in glia, ATPα levels are reduced, thus reducing the amount of
intracellular K+ within glial cells and increasing the concentration of K+ in the
extracellular space (Figure 4-10B). We propose that elevated extracellular K+ leads to the
neuronal dysfunction and seizure behavior observed in repo>Dube3a flies. Na+/K+
dysregulation has emerged as a potential cause of epilepsy as elevated levels of
extracellular K+ lead to more positive neuronal membrane potentials, tipping neuronal
networks into hyper-excitable states and precipitating seizure activity (Scharfman 2007,
Seifert and Steinhauser 2013). Our data indicate both reduced levels of the Na+/K+ pump
and reduced intracellular K+ levels in glial cells of repo>Dube3a animals which is likely
the underlying mechanism for seizure susceptibility in our fly model, and potentially
Dup15q syndrome where UBE3A levels are known to be elevated (Scoles, Urraca et al.
2011).
The glial specific transcription factor reversed polarity (repo) was initially
identified in a screen for mutants affecting the physiology of the ERG signal, and repo
mutants displayed an ERG with a positive polarity rather than the typical negative
polarity upon photoreceptor stimulation (Xiong, Okano et al. 1994). Pigment glial cells of
the eye ensheath photoreceptor neuron cell bodies while epithelial glia surround axon
terminals (Edwards and Meinertzhagen 2010). These glial cells in the Drosophila eye
strongly express ATPα (Gorska-Andrzejak 2013). It is not surprising then that
overexpression of Dube3a specifically within glial cells using the repo-GAL4 driver line
causes defects in the ERG signal, potentially through the downregulation of ATPα.
Identifying disease-relevant substrates of UBE3A has remained elusive. We
previously identified ATPα as a ubiquitin ligase substrate of Dube3a (Jensen, Farook et
al. 2013), and here we demonstrate that overexpression of Dube3a in both glia and
neurons results in reduced levels of ATPα, confirming our previous work. Glial specific
knockdown of ATPα recapitulates a portion of the seizure phenotype observed in
repo>Dube3a animals, indicating that reduced levels of ATPα in glia alone is sufficient
to generate seizures. Even though we did not detect a significant difference in ATPα
protein levels between repo-GAL4 and repo>Dube3a+ATPα, we did not fully rescue the
seizure phenotype in repo>Dube3a+ATPα compared to repo>Dube3a flies. It is possible
that slight decreases in ATPα protein levels undetectable by western blot may still result
in seizure susceptibility, or that other unidentified proteins and pathways regulated by
Dube3a contribute to seizure. These other targets may contribute substantially to the
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Figure 4-10. Proposed mechanism of seizure in repo>Dube3a animals.
A) In control flies, relatively low levels of Dube3a are present in glia, while high levels
are ATPα are present in the glial membrane. As K+ effluxes from neurons, ATPα
removes K+ from the synaptic cleft, restoring K+ gradients required for proper neuronal
function. B) In repo>Dube3a animals, elevated levels of Dube3a in glia reduce ATPα
levels in the membrane. As K+ effluxes from neurons it is not cleared from the
extracellular space, leading to hyperpolarized neurons and increasing neuronal activity,
resulting in epileptiform activity and seizures.
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variability in seizure severity in Dup15q syndrome (Battaglia 2008, Hogart, Leung et al.
2009). Taken together, reduced levels of ATPα due to elevated levels of Dube3a seems to
be driving a significant portion of the seizure phenotype observed in repo>Dube3a flies.
Human UBE3A and Drosophila Dube3a are approximately 70% identical at the
C-terminus. The two proteins are less conserved in the N-terminus which is believed to
determine substrate protein binding (Cooper, Hudson et al. 2004, Scheffner and Kumar
2014). We observed reductions in ATPα levels in both repo>Dube3a and repo>UBE3A
flies, suggesting that ATPα is a substrate of both fly Dube3a and human UBE3A. The
ability of UBE3A to downregulate ATPα is similar to or possibly exceeds the ability of
Dube3a to downregulate ATPα, yet we observed less severe seizure susceptibility in
repo>UBE3A compared to repo>Dube3a flies. As stated above, this discrepancy in
seizure severity may result from other substrate proteins or pathways that are not
conserved between Dube3a and UBE3A which contribute to seizure susceptibility and
variability. Indeed, we observed a partial rescue of seizure susceptibility when ATPα
levels were restored to near normal levels in repo>Dube3a flies, indicating that
downregulation of ATPα plays a large role in seizure susceptibility in repo>Dube3a flies.
However, seizures were not fully rescued by restoring ATPα levels, suggesting that
mechanisms other than the downregulation of ATPα, which may not be shared by
Dube3a and UBE3A, contribute to seizure susceptibility. This data is further supported
by our observations that glial specific knockdown of ATPα generates a seizure phenotype
similar in severity to repo>UBE3A flies, both of which are less severe than
repo>Dube3a flies. It is reasonable to propose, therefore, that mechanisms contributing
to seizure other than downregulation of ATPα remain to be identified.
Mammals have 3 homologs to ATPα: ATP1A1, ATP1A2, and ATP1A3. While
ATP1A1 is ubiquitously expressed and ATP1A3 is primarily found in neurons, ATP1A2 is
predominantly expressed in astrocytes (McGrail, Phillips et al. 1991). ATP1A2 mutations
cause familial hemiplegic migraine type 2 with epileptic seizures (OMIM 602481) (De
Fusco, Marconi et al. 2003, Vanmolkot, Kors et al. 2003, Jurkat-Rott, Freilinger et al.
2004, Spadaro, Ursu et al. 2004, Swoboda, Kanavakis et al. 2004, Deprez, Weckhuysen
et al. 2008, Gallanti, Tonelli et al. 2008), providing further evidence that impaired Na+/K+
pump function in glial cells causes epilepsy. It remains to be determined whether Na+/K+
pump levels are affected in the brains of individuals with Dup15q.
In repo>Dube3a flies we observed abnormal neuroanatomical structures in both
the MB and OL. Previous reports have indicated abnormal MB morphology in
homozygous Dube3a loss-of-function flies (Chakraborty, Paul et al. 2015). Here we
demonstrate that glial overexpression of Dube3a causes MB defects in a cell nonautonomous manner. Hippocampal heterotopias and malformations have been observed
in Dup15q individuals antemortem via MRI and post-mortem (Wegiel, Schanen et al.
2012, Boronat, Mehan et al. 2015). Our data suggests that elevated glial expression of
UBE3A may contribute to the development of hippocampal heterotopias and
malformations observed in Dup15q syndrome. Glia play a crucial role in the development
and organization of neural circuits (Stiles and Jernigan 2010), such that altering glial
function could profoundly impact neuronal pathfinding, altering the structure of the

57

central nervous system and affecting neuro-behavioral phenotypes such as autism or
intellectual disability in Dup15q individuals.
This is the first model of Dup15q syndrome that recapitulates the seizure
phenotype observed in Dup15q individuals as currently available mouse models do not
develop epilepsy (Nakatani, Tamada et al. 2009, Smith, Zhou et al. 2011, Krishnan,
Stoppel et al. 2017). Dup15q mouse models have focused on overexpression of Ube3a in
neurons, since Ube3a is only imprinted in neurons while glia, which biallelically express
Ube3a, have been largely ignored. During early experiments we serendipitously observed
a bang-sensitive seizure phenotype in repo>Dube3a animals simply by placing a fly vial
on the bench top or opening the incubator door, indicating a relatively severe seizure
phenotype. Individuals with Dup15q syndrome often manifest a pharmacologically
resistant form of epilepsy that progressively worsens over time, exhibiting infantile
spasms which progress to Lennox-Gastaut type syndrome (Finucane, Lusk et al. 2016).
Repo>Dube3a animals displayed a relatively mild seizure phenotype at 0-2 days of age
but by 7-10 days displayed a severe seizure behavior, similar to the progression of
seizures in Dup15q syndrome. These observations imply that seizures are not fixed but
have a developmental trajectory, suggesting that early intervention strategies may be
capable of preventing or reversing seizures.
The data presented here indicate that glial cells, not neurons, are the key cell type
responsible for seizure development in Dup15q syndrome through dysregulation of
ATPα-mediated K+ homeostasis. Recognition that glial cells contribute to the
pathophysiology and clinical manifestations of Dup15q syndrome represents a paradigm
shift in the study of Dup15q syndrome, UBE3A, and autism in general.
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CHAPTER 5. TRANSCRIPTOMIC AND PROTEOMIC PROFILING OF
GLIAL VERSUS NEURONAL DUBE3A OVEREXPRESSION REVEALS
COMMON MOLECULAR CHANGES IN GLIOPATHIC EPILEPSIES
Introduction
Epilepsy affects approximately 1% of humans worldwide in their lifetime (Fiest,
Sauro et al. 2017). Despite advances in epilepsy treatment, uncontrolled epilepsy remains
common and approximately 30-50% of people with epilepsy ultimately develop treatment
resistant seizures (Kwan and Brodie 2000, Golyala and Kwan 2017, LaPenna and
Tormoehlen 2017). Investigating the mechanism by which treatment resistant seizures
occur and identifying molecular commonalities among different genetic causes of
seizures, can help fill the gap in our knowledge about why epilepsy is refractory to many
current treatments.
One genetic disorder with a high rate of treatment resistant epilepsy that may
serve as an entry point into investigating treatment resistant seizures is Duplication 15q
syndrome, or Dup15q (Finucane, Lusk et al. 2016). Dup15q results from maternally
derived duplications of chromosome 15q11.2-q13.1 and individuals with Dup15q harbor
1 to 6 extra copies of this region. A retrospective survey on seizure in Dup15q indicated
that seizure severity was positively correlated with 15q11.2-q13.1 copy number as 25%
of interstitial duplications (1 extra copy), 64% of isodicentric duplications (2 extra
copies), and 100% of complex duplications (up to 6 extra copies) presented with seizures.
As low as 25% of individuals with isodicentric Dup15q had a >90% reduction in seizures
after the first medication, and seizures were refractory in roughly 75% of epileptic
individuals (Conant, Finucane et al. 2014).
The majority of Dup15q research has focused on neuronal overexpression of the
E3 ubiquitin ligase UBE3A. Due to the complex imprinted regulation in neurons at the
15q11.2-q13.1 locus, UBE3A is only expressed from the maternal allele in mature
mammalian neurons (LaSalle, Reiter et al. 2015). Dup15q characteristics other than
seizures have been successfully recapitulated in mouse models, such as social
abnormalities and behavioral inflexibility (Nakatani, Tamada et al. 2009), social
interaction deficits (Smith, Zhou et al. 2011), and seizure-induced decreased sociability
(Krishnan, Stoppel et al. 2017). However, modeling seizure susceptibility itself has been
difficult to do in rodent models. A recent mouse model restricting Ube3a overexpression
to excitatory neurons caused slightly reduced threshold to pharmacologically induced
seizures, yet spontaneous seizure behavior was not described (Copping, Christian et al.
2017).
To develop a seizure model of Dup15q, we turned to Drosophila melanogaster
and the powerful GAL4/UAS system (Brand and Perrimon 1993, Duffy 2002). This new
Dup15q model in flies recapitulates the seizure phenotype when Dube3a (the fly UBE3A
homolog) or human UBE3A is overexpressed in glial cells (repo>Dube3a), not neurons
(elav>Dube3a), implicating glia in the etiology of Dup15q seizures (Hope, LeDoux et al.
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2017). Glial cells biallelically express Ube3a in mice (Yamasaki, Joh et al. 2003, Dindot,
Antalffy et al. 2008, Judson, Sosa-Pagan et al. 2014, Grier, Carson et al. 2015), and
GFAP positive astrocytes in the human brain similarly express UBE3A (Burette, Judson
et al. 2018). Based on these observations, we propose that Dup15q individuals have
elevated levels of UBE3A in glia and neurons. The contribution of glial cells, particularly
astrocytes, to epilepsy is becoming more apparent (Coulter and Steinhauser 2015), and
increased UBE3A levels in human glia may cause the underlying molecular deficits that
lead to seizures in Dup15q.
Previously, we identified reduced levels of the Na+/K+ exchanger ATPα in our
glial Dube3a overexpression seizure model that appeared to drive a large portion, but not
all, of the seizure phenotype (Hope, LeDoux et al. 2017). As such, further
characterization of repo>Dube3a seizure sensitive flies was needed. In this study we
employed whole transcriptome analysis through RNA-sequencing and whole proteome
analysis through liquid chromatography coupled to high-resolution mass spectrometry of
whole fly head extracts in order to identify the underlying changes in glial or neuronal
Dube3a overexpression. By combining both transcript and protein profiling, we were
able to identify genes that were altered at either the transcript level, the protein level, or
both the transcript and protein level based on Dube3a cell-type-specific overexpression.
Methods
Fly Stocks
Flies were reared on standard corn meal media (Bloomington Stock Center) and
maintained on a 12-hour light/dark cycle at 25°C. repo-GAL4 was obtained from the
Bloomington Drosophila Stock Center (BDSC # 7415), elav-GAL4 was provided by Dr.
Hugo Bellen (Baylor College of Medicine), and UAS-Dube3a was described previously
(Reiter, Seagroves et al. 2006). The GSTD1-LacZ reporter line was provided by Mel
Feany and Dirk Bohmann and has been described previously (Sykiotis and Bohmann
2008).
The following stocks were used for gliopathic seizure screening: P(CaryP)attP2
(UAS-RNAi Control, BDSC #36303), UAS-Comt-RNAi (BDSC #31470), UAS-ComtRNAi (BDSC #31666), UAS-Comt-RNAi (BDSC #34913), UAS-eas-RNAi (BDSC
#38528), UAS-ATPα-RNAi (BDSC #32913), UAS-pk-RNAi (BDSC #32413), UASSesB-RNAi (BDSC #31230), UAS-SesB-RNAi (BDSC #31077), UAS-Tko-RNAi (BDSC
#38251), UAS-porin-RNAi (BDSC #67873), UAS-porin-RNAi (BDSC #29572), UASsyn-RNAi (BDSC #27304), UAS-Sod2-RNAi (BDSC #25969), UAS-Sod2-RNAi (BDSC
#36871), UAS-Sod2-RNAi (BDSC #32496), UAS-mt:ATPase6-RNAi (BDSC #60435),
UAS-mt:ATPase6-RNAi (BDSC #55297), UAS-TetxLC (BDSC #28997), UAShtt.128Q.FL (BDSC #33808), UAS-Jbug-RNAi (BDSC#39070), UAS-Jbug-RNAi
(BDSC #31590), UAS-Sirup-RNAi (BDSC #43213), UAS-Ttc19-RNAi (BDSC #64958),
UAS-YME1L-RNAi (BDSC #31752), UAS-levy-RNAi (BDSC #67789), UAS-ST6GAL-
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RNAi (BDSC #44528), UAS-ST6GAL-RNAi (BDSC #53907), UAS-ST6GAL-RNAi
(BSDC #65876), UAS-ncc69-RNAi (BDSC #28682), UAS-atl-RNAi (BDSC #36736),
UAS-COX7A-RNAi (BDSC #57572), UAS-Tpi-RNAi (BDSC #51829), UAS-Tpi-RNAi
(BDSC #26304), UAS-sra-RNAi (BDSC #27260), UAS-sra-RNAi (BDSC #36900),
UAS-kcc-RNAi (BDSC #34584), UAS-kdn-RNAi (BDSC #36740), UAS-cac-RNAi
(BDSC #27244), UAS-Cpo-RNAi (BDSC #28360), UAS-Cpo-RNAi (BDSC #60388),
UAS-GFAP (BDSC #64368), UAS-zyd-RNAi (BDSC #25851), UAS-stai-RNAi (BDSC
#53925), UAS-stai-RNAi (BDSC #36902), UAS-Para-RNAi (BDSC #31676), UASPara-RNAi (BDSC #33923), UAS-Para-RNAi (BDSC #31471), UAS-Letm1-RNAi
(BDSC #37502), UAS-nrv2-RNAi (BDSC #28666), UAS-nrv2-RNAi (BDSC #37495),
UAS-CG9657-RNAi (BDSC #28384), UAS-sei-RNAi (BDSC #31681), and UAS-SeiRNAi (BDSC #31682).
RNAsequencing
RNA was isolated from control (UAS-Dube3a alone), glial Dube3a
overexpression (repo>Dube3a), or neuronal overexpression of Dube3a (elav>Dube3a)
flies by removing 15-25 fly heads per genotype and homogenizing in TRI Reagent
(Applied Biosystems). Total RNA was extracted with Directzol RNA MiniPrep Plus
(Zymo Research Corp) according to the manufacturer’s instructions which included a
DNAse treatment step. Purity and concentration was verified using NanoDrop
spectrophotometer (ThermoFisher Scientific), and integrity was confirmed using a
Bioanalyzer (Agilent). Each genotype was run in triplicate. RNAseq was performed by
PGM sequencing at the UTHSC Molecular Resource Center (MRC). Each RNA sample
was converted to ion torrent sequencing libraries and run on 318v2 chips using an Ion
Torrent Proton sequencer. All groups and replicates were run simultaneously to eliminate
chip-to-chip variability.
RNAseq Analysis
At least 35M unmapped reads we available per replicate sample for three groups
and three replicates (1) UAS-Dube3a, (2) repo>Dube3a, (3) elav>Dube3a. RNAseq
alignments and analysis was performed using a local Slipstream appliance running a
GALAXY installation. All FASTQ files were gathered from the sequencer. Quality
assurance was performed using FASTQC. All reads were trimmed to remove any
nucleotide that fails a phred score < Q20. The trimmed FASTQ files were aligned to the
reference library using RNA STAR. Once aligned, the SAM files were collected and
mined for read count information of each gene present in the reference file. Read counts
were normalized using Transcripts per Million (TPM) method across the entire
experiment. The resulting data was analyzed with DeSeq2. All genes that failed to yield
at least a 1.5-fold change and a p-value greater than 0.05 were removed. Benjamini and
Hochberg false discovery rate was performed on the trimmed gene list. All genes that
failed to yield a false discovery rate < 0.05 were removed. The final significant
differential gene list were loaded into R for visualization.
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Quantitative Proteomics
Protein was extracted from fly heads by homogenizing 30-40 fly heads of each
genotype in RIPA buffer plus complete Protease Inhibitor Cocktail (Roche). Lysates were
de-salted and immobilized using a Filter Aided Sample Preparation (FASP) column
followed by trypsin digestion and Tandem Mass Tag (TMT) labeling as described
elsewhere (Jiang, Bomgarden et al. 2017). All groups were labeled at once to avoid
variance in labeling reactions. The labeled digested peptides were then were analyzed by
LC-MS/MS using an EASY-nLC 1000 UPLC system (Thermo Fisher Scientific San Jose,
CA) with a 50 cm EASY-Spray Column coupled to an Orbitrap Fusion Lumos (Thermo
Fisher Scientific, San Jose, CA) mass spectrometer. Separations were carried out using a
210 min gradient at a flow rate of 300 nL/min.
Post-acquisition analysis of raw MS data was performed with mass informatics
platform Proteome Discoverer 2.0 and searched with the SEQUEST HT search engine.
Precursor mass tolerance was set to 10 ppm. Fragment ion tolerance was 0.02 Da when
using the Orbitrap analyzer and 0.6 Da when using the ion trap analyzer.
Carbamidomethylation on cysteine (+57.021 Da) and TMT6 tags on N termini as well as
lysine (+229.163 Da) were set as static modifications. Dynamic modifications included
oxidation on methionine (+15.995 Da). Data were searched against a UniProt Drosophila
melanogaster database. Peptide identification data was used for identification and
quantification of corresponding parent proteins; Peptide abundance was calculated using
signal to noise (S/N) values from corrected reporter ion abundances based on the
manufacturer’s data sheets. S/N values where then log transformed and roll up at the
protein level by summing the values for all the peptides to represent protein abundance.
An ANOVA test was then performed to determine statistically relevant differences. For
statistical validation of results, the FDR (False Discovery Rate) was determined and
differences were considered statistically significant if FDR < 0.05.
Combined RNAseq and Proteomic Analysis
RNAseq and proteomics data were combined into a single analysis by selecting
proteins that were significantly differentially expressed that were also detected at the
transcript level. Protein abundance ratios were used to calculate the protein Log2 fold
change and FPKM were used to calculate transcript Log2 fold change.
Quantitative Western Blot Analysis
Protein was extracted from 30-40 fly heads by homogenization in RIPA buffer
plus Complete Protease Inhibitor Cocktail (Roche). Samples were spun at 10,000 x g to
remove exoskeleton. 20 μg of protein was loaded into 1.5 mm NuPAGE Bis-Tris 4-12%
gels (Invitrogen) and subsequently transferred to PVDF membranes (Millipore).
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Membranes were blocked with Odyssey Blocking Buffer (Li-Cor cat # 927-50000). The
following primary antibodies were diluted in Odyssey Blocking Buffer with 0.2% tween20: α-GAPDH (1:5000, Abcam ab157156), α-futsch (1:100, DSHB, 22C10), α-synapsin
(1:100, DSHB, 3C11), α-Sap47 (1:100, DSHB, nc46), α-Syx1a (1:100, DSHB, 8C3), and
α-Nwk (1:1000, gift from J. Troy Littleton (Picowar Institute at MIT)). The following
infrared secondary antibodies were diluted at 1:15,000 in Odyssey Blocking Buffer with
0.2% tween-20 and 0.01% SDS: α-goat (Licor Cat# 925-68074), α-mouse (Licor Cat#
926-32212), and α-rabbit (Licor Cat# 925-32211). Blots were imaged using an Odyssey
Infrared Imaging System (Licor) and analyzed using Image Studio Lite (Licor)
normalizing experimental bands to GAPDH as the loading control for calculating
normalized adjusted relative signal intensities. All samples were run ≥ 3 times to perform
statistical analysis, and differences were considered statistically significant if p < 0.05.
Seizure Susceptibility Assays
Flies were collected on the day of eclosure under CO2 anesthesia and aged 3-5
days. On the day of testing flies were gently transferred by mouth pipette to empty vials.
Flies were subjected to mechanical stress (“bang”) by vortexing for 10 s on a standard
laboratory vortexer (LabNet) at full speed. Recovery time was recorded for each fly as
measured by time until the fly righted itself and was able to walk or groom and no longer
displayed paralysis or uncontrolled muscle movements. To detect seizure sensitive flies,
all experimental groups were compared to the control repo>36303-emptyvector-RNAi by
one-way ANOVA followed by Dunnett’s multiple comparison test. Groups were
considered statistically significant if p < 0.05.
Microarray Analysis
Total RNA was isolated from control (repo>36303-emptyvector-RNAi) and
gliopathic seizure lines by removing 15-25 fly heads per genotype and homogenizing in
TRI Reagent (Applied Biosystems) and followed by RNA purification with Directzol
RNA MiniPrep Plus (Zymo Research Corp) according to the manufacturer’s instructions.
Purity and concentration were verified using NanoDrop spectrophotometer
(ThermoFisher Scientific) and Qubit (ThermoFisher Scientific). RNA integrity was
measured using a Bioanalyzer (Agilent). mRNA from the gliopathic seizure flies was
pooled into a single group by adding equal amounts of mRNA from each sample.
Samples were run on a GeneChip Drosophila Gene 1.0 ST Array (ThermoFisher
Scientific, #902155).
CSV files were retrieved from UTHSC Molecular Resource Center after
normalization performed by Affymetrix Expression Console. Quality assurance was
checked against reference probes to ensure quality of data. Gene names, accession
numbers, and expression were mined from each text file for each sample. All nonannotated information was removed from the file leaving only annotated gene expression.
A Welsh t test was run for pairwise interactions in order to obtain p-values for
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significance. Only genes with a p-value < 0.05 were considered significant. The mean,
variance, standard deviation, and fold change were calculated for each pairwise
comparison. Benjamini Hochberg false discovery rate method was applied in order to
obtain the adjusted p-value for each gene. Only genes with an adjusted p-value < 0.05
were considered significant.
Quantitative Real-time Polymerase Chain Reaction (qRT-PCR)
mRNA was converted to cDNA using a Transcriptor First Strand cDNA Synthesis
Kit (Roche, 04379012001) according to the manufacturer’s instructions. Briefly, 500 ng
of total mRNA was used per genotype with random hexamer primers for cDNA
synthesis. Probes were selected and primers were designed using the Universal Probe
Library Assay Design Center software (Roche). The following primers were used with
probe #61 from the Universal Probe Library (UPL) for GstS1: F 5’AAGGACAACGATGGTCACCT-3’, R 5’-GATGCCTGCGAAGTAGACG-3’. For
GstD2, the following primers were used with UPL probe #5: F: 5’TTCTCGACACCTTCCTGGAG-3’, R 5’-AGTGGACAGGATGGCAATGT-3’. For
GstE7, the following primers were used with UPL probe #25: F: 5’AATACGGCAAAACGGACAGT-3’, R 5’-AATCGCTGATCCACGACAG-3’. For
GstD5, the following primers were used with UPL probe #55: F: 5’CCACCTCACAGTGGCTGATA-3’, R 5’-TCAAAGATTTCGAAAGTGGAAAC-3’.
For tbp, the following primers were used with UPL probe #109: F: 5’ACAGGGGCAAAGAGTGAGG-3’, R 5’-CTTAAAGTCGAGGAACTTTGCAG-3’.
All assays were performed in triplicate for each cDNA sample. Cycling
conditions of the Roche LC480 were: 95°C for 5 m followed by 40 cycles of 95°C for 10
s, 60°C for 30 s, and 72°C for 10 s during which fluorescence was measured. Crossing
point (Cp) values were calculated for each sample using the absolute quantification
algorithm (Roche), and average Cp values for three technical replicates were calculated.
The average Cp values were normalized to TATA-binding protein (tbp). Log2 fold change
was calculated by first finding the ∆Cp for each sample, comparing experimental groups
to the control group to calculate ∆∆Cp, calculating fold change with the equation Fc =
(2)-∆∆Cp, and finally making the Log2 transformation.
Immunohistochemistry and Image Acquisition
Flies were anesthetized with CO2 and brains were dissected in phosphate buffered
saline (PBS) and fixed with 4% formaldehyde for 1 hour. Brains were blocked and
permeabilized with 5% bovine serum albumin and 0.1% Triton X-100. Primary
antibodies used were rabbit α-Gal (1:100, Thermofisher Scientific 14-6773-81) and
mouse α-repo (1:100, DSHB 8D12), incubated overnight at 4ºC in the same blocking
solution. Secondary antibodies used were donkey α-rabbit 594 (1:500, Thermofisher
Scientific A21207) and goat α-mouse 488 (1:500, Thermofisher Scientific A11029) and
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were incubated for 1 hour at room temperature. Slides were mounted with FluoromountG mounting media (SouthernBiotech, 0100-20) and sealed with clear nail polish.
Confocal images were acquired using a Zeiss 710 laser scanning confocal
microscope (Zeiss) located in the UTHSC Neuroscience Institute Imaging Core. Images
were captured at 1024x1024 resolution with a 63X objective lens at 1 µM Z-section
thickness. Detector gain and offset were optimized for the control group and settings
were kept consistent across treatment groups to allow for comparisons between groups.
Feeding Flies Picrotoxin (PTX)
A 50 mM stock solution of PTX (Acros Organics) was made in DMSO. Flies
were fed 2.5 mM PTX in 5% sucrose (Sigma) with 1% green food color by placing flies
in a vial containing a Kimwipe saturated with PTX feeding solution. Flies were left to
feed for 24 hours, and consumption was confirmed by the presence of green dye in their
abdomens. Control flies were fed DMSO alone.
Data Analysis
Data analysis and statistical tests were performed using Prism 6.0 (GraphPad). To
determine differences between multiple samples, one-way ANOVA was used with
Tukey’s multiple comparisons (α was set to 0.05). Heatmaps were generated using RStudio and figures were generated in Adobe Illustrator (Adobe).
Results
Transcriptomic Profiling Reveals an Upregulation of Glutathione S-transferases in
repo>Dube3a Fly Heads
We previously demonstrated that repo>Dube3a flies overexpressing Dube3a in
all glial cells display a severe bang-sensitive seizure phenotype, while elav>Dube3a flies
expressing Dube3a in all neurons do not (Hope, LeDoux et al. 2017). In order to
investigate gene expression changes in these animals at the transcript level we performed
RNAseq using RNA extracted from whole fly heads in control UAS-Dube3a alone, glial
Dube3a overexpression repo>Dube3a, and neuronal Dube3a overexpression
elav>Dube3a flies. We reliably identified and quantified transcripts from approximately
11,000 genes across all three groups. We found 851 differentially expressed genes in
repo>Dube3a compared to UAS-Dube3a controls and 495 differentially expressed genes
in elav>Dube3a compared to controls (p-adjusted < 0.05). Of these differentially
expressed transcripts, 180 were shared between repo>Dube3a and elav>Dube3a (Figure
5-1A, Supplemental RNAseq Data).
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Figure 5-1. Transcript profiling reveals an upregulation of GST genes in
repo>Dube3a flies.
A) Venn diagram of differentially expressed transcripts between repo>Dube3a and
elav>Dube3a compared to UAS-Dube3a controls. B) DAVID enrichment groups for
differentially expressed transcripts in each portion of the Venn diagram. C) Heatmap
indicating an upregulation of 13/14 GST genes in repo>Dube3a. This upregulation was
not observed in neuronal elav>Dube3a overexpression. D) Heatmap illustrating the
differential expression for the “ligand-gated channel” enrichment group observed in
elav>Dube3a.
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To identify biological enrichments within each portion of the Venn diagram, we
utilized the Database for Annotation, Visualization, and Integrated Discovery (Huang da,
Sherman et al. 2009, Huang da, Sherman et al. 2009), and plotted DAVID analysis
enrichment groups with an enrichment score (ES) greater than 2 for each group (Figure
5-1B). In the 180 differentially expressed genes shared between repo>Dube3a and
elav>Dube3a, we observed an enrichment in “insect cuticle proteins” (ES = 5.46),
“oxidoreductase” (ES = 2.73), and “neuropeptide” (ES = 2.09), (Fig. 1B). Within the 671
repo>Dube3a specific differentially expressed genes we found the strongest enrichment
in “glutathione S-transferase” (ES = 7.96). For the 315 elav>Dube3a specific
significantly differentially expressed transcripts we observed an enrichment in “ligandgated channel activity” (ES = 2.29) and “positive regulation of NFAT protein import into
nucleus” (ES = 2.07) (Figure 5-1B, for all enrichment groups see Supplemental
RNAseq Data). We plotted the Log2 fold change for GST enrichment observed in
repo>Dube3a for repo>Dube3a and elav>Dube3a compared to controls and observed an
upregulation of 13/14 GST genes and a downregulation of GstE2 in repo>Dube3a that
remained largely unchanged in elav>Dube3a (Figure 5-1C). We also plotted the Log2
fold change for the ligand-gated channel enrichment from elav>Dube3a for
repo>Dube3a and elav>Dube3a compared to controls (Figure 5-1D). These results
indicate that overexpression of Dube3a in glial cells has a stronger impact on the global
transcriptome compared to neuronal Dube3a overexpression. Additionally,
overexpression of Dube3a in glia causes both seizures and an upregulation of GST genes,
and the upregulation of GSTs within glial cells occurs in idiopathic treatment resistant
epilepsy (Shang, Liu et al. 2008).
Proteomic Profiling Reveals Differential Expression of Neurotransmitter Secretion
Proteins in repo>Dube3a Fly Heads
Next, we investigated global changes at the protein level using quantitative
proteomics through mass spectrometry. We reliably identified and quantified
approximately 2,500 proteins across each sample. 364 proteins were differentially
expressed (FDR < 0.05) in repo>Dube3a compared to control UAS-Dube3a, and 137
were differentially expressed (FDR < 0.05) in elav>Dube3a compared to UAS-Dube3a
flies. Of these differentially expressed proteins, 85 were shared between repo>Dube3a
and elav>Dube3a (Figure 5-2A, see Supplemental Proteomics Data). The 85 shared
differentially expressed proteins were significantly enriched in three groups with an ES >
2.0; “muscle cell development” (ES = 4.58), “Sulfation” (ES = 2.55), and “Actin” (ES =
2.72) (Fig. 2B, Supplemental Table 4). The enrichment of the GO term “muscle cell
development” was initially concerning, suggesting possible contamination in the protein
prep. The proteins included in the enrichment group are futsch, wupa, mf, up, act88f, and
prm, all of which were detected in proteomic analysis of adult Drosophila heads in
previous studies (Aradska, Bulat et al. 2015). Additionally, futsch is found at the
neuromuscular junction (NMJ) causing futsch to be included in the GO term “muscle cell
development”, however futsch is known to be expressed from the neuronal side at the
NMJ and is expressed widely throughout the central nervous system (Hummel, Krukkert

67

Figure 5-2. Proteomic profiling reveals differential expression of
neurotransmitter secretion proteins in repo>Dube3a flies.
A) Venn diagram of differentially expressed proteins between repo>Dube3a and
elav>Dube3a. B) DAVID enrichment groups with an enrichment score greater than 2 for
differentially expressed proteins for each portion of the Venn diagram. C) Normalized
abundance ratios for the two detected isoforms of the Na+/K+ ATPase ATPα following
overexpression of Dube3a in glia or neurons compared to controls indicates
downregulation of both isoforms only in repo>Dube3a fly heads. D) Normalized
abundance ratios for proteins previously reported to be regulated in a Dube3a dependent
manner. Error bars represent S.E.M, and * = FDR < 0.05, ** = FDR < 0.01, and *** =
FDR < 0.005.

68

et al. 2000), alleviating our concerns. The 279 repo>Dube3a specific differentially
expressed proteins were significantly enriched in 11 groups with an ES > 2.0, the top two
being “neurotransmitter secretion” (ES = 6.27) and “phototransduction” (ES = 4.45)
(Figure 5-2B, Supplemental Proteomics Data). Within the 52 elav>Dube3a specific
differentially expressed proteins, no enrichment group was observed with an ES > 2.0,
however the top enrichment was “stress response” (ES = 1.96). Similar to our RNAseq
data, these results suggest that overexpression of Dube3a in glia causes a larger change in
the global proteomic landscape of the fly brain compared to overexpression of Dube3a in
neurons. Additionally, we observed an enrichment in the GO term “neurotransmitter
secretion” and “phototransduction” which are predominantly neuronal processes,
suggesting cell non-autonomous effects of glial Dube3a overexpression in repo>Dube3a
flies.
We previously reported downregulation of ATPα upon overexpression of Dube3a
in glial cells (Hope, LeDoux et al. 2017) and that ATPα can be ubiquitinated by Dube3a
(Jensen, Farook et al. 2013). We detected two peptides that mapped to two different
isoforms of ATPα and we observed significantly reduced ATPα levels in the
repo>Dube3a group for both ATPα accession P13607 (p < 0.0005) and for ATPα
accession E1JIR4 (p < 0.01), however we did not observe significant reductions in either
isoform of ATPα in elav>Dube3a flies (Figure 5-2C). These results confirm our prior
findings that elevated levels of Dube3a in glial cells results in reduced levels of ATPα
protein (Hope, LeDoux et al. 2017). Additionally, we checked the levels of other proteins
found to be influenced by Dube3a. Actin, Actin-57B, and apolipophorins were previously
reported to be upregulated following elevated levels of Dube3a protein by our group
(Jensen, Farook et al. 2013). Here we observed an upregulation of both Actin and
Actin57B in both repo>Dube3a and elav>Dube3a, and apolipophorins was only
upregulated in repo>Dube3a (Figure 5-2D), confirming our previous proteomics results
(Jensen et al., 2013). Rpn10 has been reported as a direct Ube3a substrate (Lee, Ramirez
et al. 2014), however we detected no significant difference in Rpn10 levels in
elav>Dube3a or repo>Dube3a, with levels slightly, but not significantly, increased in the
repo>Dube3a group (Figure 5-2D).
Comparison of the Transcriptome and the Proteome Reveals Downregulation of
Synaptic Transmission Proteins in repo>Dube3a Fly Heads
We compared the proteome and the transcriptome to determine whether
expression changes at the protein level could be explained by changes at the transcript
level. We selected all differentially expressed proteins that were also detected at the
transcript level and mapped the Log2 fold change of both the transcript and protein for
repo>Dube3a compared to UAS-Dube3a (Figure 5-3A, Supplemental Repo Quadrant
Analysis) and for elav>Dube3a compared to UAS-Dube3a (Figure 5-3B, Supplemental
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Figure 5-3. Cell non-autonomous downregulation of synaptic transmission
proteins in repo>Dube3a flies.
A) Log2 fold change of significantly differentially expressed proteins also detected at the
transcript and protein level in repo>Dube3a and B) Log2 fold change of significantly
differentially expressed proteins also detected at the transcript level. The top DAVID
enrichment group is stated in each quadrant of the graph. C) Heatmap of genes at the
transcript and protein level for the “synaptic transmission” enrichment group in both
repo>Dube3a and elav>Dube3a. Note the cell non-autonomous downregulation
observed for neuronal proteins in repo>Dube3a brain. D) Quantitative IR Western blot
confirmation of “synaptic transmission” protein downregulation in both repo>Dube3a
and elav>Dube3a. N ≥ 3 for each genotype, error bars represent S.E.M., and * = p <
0.05, ** = p < 0.01, and *** = p < 0.005.
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Elav Quadrant Analysis). Quadrants I, II, III, and IV represent genes upregulated at
both the protein and transcript level, genes upregulated at the protein level but
downregulated at the transcript level, genes downregulated at both the protein and
transcript level, and genes downregulated at the protein level but upregulated at the
transcript level, respectively. In quadrant III of repo>Dube3a we observed a significant
DAVID enrichment in the GO term “synaptic transmission” (Enrichment Score = 15.7).
This enrichment included 21 genes, and we plotted Log2 fold change values for each gene
at the protein and transcript level in both repo>Dube3a and elav>Dube3a (Figure 5-3C)
all of which are downregulated in repo>Dube3a but relatively unchanged in
elav>Dube3a flies. These data suggest cell non-autonomous effects of Dube3a
overexpression in glia, whereby glial elevation of Dube3a causes downregulation of
neuronal synaptic transmission proteins.
Next, we tried to validate the downregulation of synaptic proteins observed
through RNAseq and proteomics via western blot (Figure 5-3D). We observed a
significant effect of genotype on synapsin levels (One-way ANOVA, F(2,6) = 35.91, p <
0.005), a vesicle protein that regulates neurotransmitter release (Winther, Vorontsova et
al. 2015), and found that synapsin is downregulated at the protein level in repo>Dube3a
compared to control UAS-Dube3a flies (Tukey’s multiple comparisons; p < 0.005). We
found a downregulation of synapsin in elav>Dube3a compared to UAS-Dube3a flies
(Tukey’s multiple comparisons; p < 0.01) that was not detected during our proteomic
analysis. In addition to synapsin, we confirmed the downregulation of Sap47, a vesicle
associated protein (Saumweber, Weyhersmuller et al. 2011), at the protein level with
genotype displaying a significant effect on Sap47 levels (One-way ANOVA, F(2,6) =
49.38, p < 0.005). We observed reduced Sap47 levels in repo>Dube3a compared to
UAS-Dube3a flies (Tukey’s multiple comparisons; p < 0.005) and in elav>Dube3a flies
(Tukey’s multiple comparisons; p < 0.005). Although not detected in our proteomics
dataset, we tested levels of the neuronal microtubule protein futsch and detected a
significant downregulation of futsch protein levels in repo>Dube3a compared to UASDube3a alone (One-way ANOVA, F(2,6) = 5.18, p < 0.05, Tukey’s multiple comparisons;
p < 0.05). Syx1a mediates vesicle fusion (Schulze, Broadie et al. 1995), and Syx1a
protein expression was also dependent upon genotype (One-way ANOVA, F(2,21) = 5.75,
p < 0.05), and levels were significantly reduced only in repo>Dube3a compared to UASDube3a controls (Tukey’s multiple comparisons, p < 0.05). We also tested levels of Nwk,
a protein that regulates synapse morphology and actin dynamics (Rodal, Motola-Barnes
et al. 2008), however there was slightly more variation and no significant differences
were detected between genotypes (One-way ANOVA, F(2,21) = 2.43, p = 0.11). Taken as a
whole, our Western blot data verifies the results from our proteomics data that in general,
synaptic proteins are downregulated in repo>Dube3a flies in a cell non-autonomous
manner as we are manipulating Dube3a expression in glial cells.
Glutathione S-transferase Upregulation is Common Among Gliopathic Seizure Flies
We wanted to know whether any of the molecular changes that occur in our
Dup15q fly model of epilepsy were common to other epilepsies studied in flies and if
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these “bang sensitive” genes had anything to do with glial cells. We identified and
selected 54 different UAS lines that covered 34 genes which were associated with the
term “bang sensitive” in FlyBase and crossed these UAS-RNAi or UAS-cDNA lines to
repo-GAL4 to manipulate gene expression within glial cells. Lethality was observed in 6
of these lines, including UAS-porin-RNAi (BDSC #67873), UAS-TetxLC (BDSC
#28997), UAS-Jbug-RNAi (BDSC #39070), UAS-Zyd-RNAi (BDSC #25851), UASLetm1-RNAi (BDSC #37502), and UAS-nrv2-RNAi (BDSC #28666). We identified 6
additional lines that cause a bang sensitive seizure phenotype when crossed to repoGAL4 (Figure 5-4A, One-Way ANOVA, F(48,532) = 46.17, p < 0.0001; Dunnett’s
multiple comparison test p < 0.05). We called these flies “gliopathic” seizure flies
because they have seizures driven by glial cell manipulations, most of which were RNAi
knockdown of endogenous glial genes. Total head mRNA was collected from 5 of these
gliopathic lines along with repo>Dube3a, pooled into one group, and an mRNA
microarray analysis was performed to look for shared transcriptional changes among all
of the lines (repo>COX7A-RNAi was excluded from the microarray due to a less severe
seizure phenotype, however it was included in subsequent qRT-PCR analysis). Upon
comparing the gliopathic seizure group to a repo>36303-emptyvector-RNAi control line,
we observed 120 significantly differentially expressed transcripts (FDR < 0.05,
Supplemental Microarray Data). DAVID analysis of these differentially expressed
genes revealed a significant enrichment in the GO term “Detoxification” (ES = 2.45),
comprising the GSTs GSTD2, GSTD5, and GSTS1. Additionally, we observed an
enrichment in “glutathione S-transferase activity” (ES = 2.31), including the additional
gene GSTE7 (Supplemental Microarray Data). Upon performing qRT-PCR for GSTS1,
GSTD2, GSTE7, and GSTD5 on each individual line, we confirmed an upregulation of
these GST transcripts in 5 out of the 7 gliopathic seizure lines (Figure 5-4B). These data
indicate that GST upregulation is a common occurrence in gliopathic seizure and is not a
phenomenon specific to our fly model of Dup15q epilepsy.
To determine whether the upregulation of GSTs occurred cell autonomously
within glia or non-autonomously within some other cell type in the brain, such as
neurons, we used a previously published GSTD1-LacZ reporter line (Sykiotis and
Bohmann 2008). In control repo-GAL4;GSTD1-LacZ flies staining for α-Gal was
relatively diffuse (Figure 5-4C, top row). However, in repo>Dube3a;GSTD1-LacZ
seizure flies we observed a marked increase in α-Gal immunoreactivity which
colocalized strongly with the glial-specific transcription factor repo (Figure 5-4C,
bottom row). Finally, we asked whether inducing seizure-like activity alone through
pharmacological means would similarly result in GST upregulation. We fed GSTD1LacZ flies 2.5 mM picrotoxin (PTX) or DMSO (control) overnight to induce seizure-like
behavior, and upregulation of GSTD1-LacZ did not occur PTX fed flies (Figure 5-5).
Taken together, these data suggest that GST upregulation is common among gliopathic
seizure flies and occurs cell autonomously within glial cells.
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Figure 5-4. Glutathione S-transferase upregulation is common among multiple
“gliopathic” seizure lines and occurs cell autonomously within glial cells.
A) Recovery times in the bang sensitivity seizure assay for 6 additional gliopathic seizure
lines identified. B) Heatmap of glutathione S-transferase expression levels in each
gliopathic seizure line indicates upregulation of glutathione S-transferases in 5/7 lines.
Genes were originally identified by microarray as differentially expressed in a pooled
gliopathic seizure group compared to a control group. C) Immunohistochemistry in repoGAL4;GstD1-LacZ or repo>Dube3a;GstD1-LacZ for the glutathione S-transferase
reporter GstD1-LacZ (red) reveals an upregulation of glutathione S-transferases cell
autonomously within glial cells. All glial cells are marked with an α-repo antibody
(green). Error bars represent S.E.M. and scale bars represent 25 µm or 5 µm (inset).
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Figure 5-5. Glutathione S-transferase upregulation is not observed in flies fed
PTX.
Overnight feeding of PTX (bottom row) did not induce expression of the GstD1-LacZ
reporter (red) compared to DMSO control (top row). Glial cells are marked with α-repo
antibody (green). Scale bar is 25 µm.
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Discussion
In this study we show that glial Dube3a overexpression causes downregulation of
synaptic transmission genes at the transcript and protein levels. We also demonstrate a
cell autonomous upregulation of GSTs that was shared among multiple gliopathic seizure
lines that we identified. In contrast, Dube3a overexpression in neurons resulted in fewer
overall changes in the transcriptome and proteome, and fewer biologically relevant
enrichment groups compared to Dube3a overexpression in glia. This study demonstrates
the utility of Drosophila for identifying global changes in the transcriptome and proteome
depending on the cell type overexpressing Dube3a (glia or neurons). We went on to show
shared molecular changes across multiple genes causing gliopathic seizure.
Our proteomic experiments identified a sizeable portion of the Drosophila head
proteome. While not exhaustive, we reliably measured peptides corresponding to 2,503
proteins. Recent efforts to completely identify the Drosophila head proteome revealed
peptides corresponding to 4,559 proteins (Aradska, Bulat et al. 2015). Despite the lower
coverage, we observed synaptic transmission protein downregulation in repo>Dube3a
flies which we confirmed via western blot. Importantly, these experiments were not
designed to detect direct ubiquitin ligase substrates of Dube3a, only the consequences of
Dube3a overexpression in different cell types. As such, the changes observed at the
protein level could be secondary, tertiary, or even quaternary effects due to Dube3a
overexpression. We observed an enrichment of downregulated proteins in the gene
ontology term “synaptic transmission” in repo>Dube3a flies, suggesting cell nonautonomous effects of Dube3a overexpression in glia. Some of these genes are expressed
in glia and contribute to the synaptic transmission process, such as glutamine synthetase 2
(Gs2) which converts glutamate to glutamine (Sinakevitch, Grau et al. 2010). However,
genes including futsch (Hummel, Krukkert et al. 2000), synapsin (Oland, Biebelhausen et
al. 2008), Sap47 (Reichmuth, Becker et al. 1995, Saumweber, Weyhersmuller et al.
2011), bruchpilot (Wagh, Rasse et al. 2006), and nervous wreck (Rodal, Motola-Barnes
et al. 2008) are predominantly expressed in neurons. Therefore, our results show that
repo>Dube3a has a cell non-autonomous effect on gene expression in neurons.
Human orthologs of some of the synaptic transmission proteins downregulated in
repo>Dube3a flies are associated with human epilepsy. Nonsense variants in Synapsin I,
the human ortholog of Drosophila synapsin, were identified in two separate families
segregating epilepsy and in an ASD/epilepsy cohort (Garcia, Blair et al. 2004, Fassio,
Patry et al. 2011). Drosophila Syx1a is orthologous to human STX1B, and mutations in
STX1B are associated with febrile seizures and epilepsy (Schubert, Siekierska et al.
2014). The data from our fly model suggests these proteins may be implicated in Dup15q
epilepsy, and alterations in these synaptic proteins in the Dup15q brain remain to be
explored.
Glial GST upregulation may broadly underlie treatment resistant epilepsies. GSTs
are upregulated in the human brain in cases of treatment resistant epilepsy, particularly in
astrocytes surrounding blood vessels (Shang, Liu et al. 2008). While the factor initiating
GST upregulation in seizure remains unknown, we show here that chemical induction of
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seizure activity did not result in GST up regulation, implying the neuronal activity alone
is not the cause. GST upregulation occurred within glia in response to oxidative stress in
a fly model of Alexander disease (Wang, Colodner et al. 2011, Wang, Hagemann et al.
2016) and in a mammalian in vitro culture system during increased neuronal activity
(McGann and Mandel 2018). One hypothesis surrounding GSTs in treatment resistant
epilepsy is glia of the blood brain barrier upregulate GSTs, whether from oxidative stress
or increased neuronal activity during seizure, causing antiepileptic drug metabolism
before they enter the brain. Indeed, in cancer GST upregulation is associated with
increased drug metabolism and chemoresistance (Sau, Pellizzari Tregno et al. 2010,
Allocati, Masulli et al. 2018), suggesting GST upregulation as a cause of treatment
resistant epilepsy as well.
In conclusion, we found cell non-autonomous downregulation of synaptic
transmission proteins in repo>Dube3a flies combined with GST upregulation not only in
Dup15q related repo>Dube3a animals but across gliopathic epilepsies we tested. Our
results highlight the use of Drosophila for investigating cell-type-specific genetic
manipulations and provides novel avenues to investigate in Dup15q and treatment
resistant epilepsy.
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CHAPTER 6.

DISCUSSION AND FUTURE DIRECTIONS

Imprinting Status of UBE3A in Drosophila
In 1970 reports of genomic imprinting came from observations that maize kernel
coloring can be directly associated with the parent of origin of certain traits, rather than
traditional dominant/recessive inheritance (Kermicle 1970). Genomic imprinting has
since been observed in both flowering plants and placental mammals (Feil and Berger
2007), but not other lineages. UBE3A demonstrates genomic imprinting in mature
mammalian neurons where it is exclusively expressed from the maternal allele (Albrecht,
Sutcliffe et al. 1997, Rougeulle, Glatt et al. 1997, LaSalle, Reiter et al. 2015). Despite a
lack of evidence for any gene to be imprinted in insects, a report suggested imprinted or
preferential expression of Dube3a in Drosophila (Chakraborty, Paul et al. 2015). In
chapter 2 we present data demonstrating that Dube3a is not imprinted nor preferentially
expressed from either allele in Drosophila (Hope, LeDoux et al. 2016). While the
emergence of the UBE3A gene is ancient, appearing after amoebozoa and before fungi,
the emergence PWS-AS imprinting domain is not, and is found in only animal lineages
after the opossum (Sato 2017). Our data indicating bi-allelic expression of Dube3a in
Drosophila neurons is consistent with the current dogma that only flowering plants and
placental mammals undergo genomic imprinting (Feil and Berger 2007).
Interaction Between UBE3A and HERC2
Until now, the interaction between UBE3A and HERC2 was predominantly
studied using in vitro biochemical methods (Kuhnle, Kogel et al. 2011, Galligan,
Martinez-Noel et al. 2015). Although in vitro evidence is clear that the RLD2 domain of
HERC2 can directly interact with UBE3A causing an increase in UBE3A ubiquitin ligase
activity, these interactions had not been shown to be occurring in vivo. In Chapter 3 we
showed that the interaction between Drosophila Dube3a and HERC2 confirms the
interaction observed with the mammalian homologs in vitro by increasing the ubiquitin
ligase activity of Dube3a. This interaction also has measurable behavioral outcomes that
appear to be the consequence of this interaction. We observed a synergistic interaction
between Dube3a and HERC2 in social interaction and circadian rhythms where defects
were only observed when both genes were overexpressed, implying that both proteins
must interact for these phenotypes. These data suggest that genes located within the
15q11.2-q13.1 other than UBE3A are contributing to Dup15q phenotypes and that these
genes should not be overlooked when investigating Dup15q syndrome.
Recent work demonstrates that the binding of E6 to UBE3A acts as an allosteric
modulator, altering the conformational shape of the UBE3A protein and through this
steric change alters the ubiquitin ligase substrates identified by UBE3A (Sailer,
Offensperger et al. 2018). Through these conformational changes, in the presence of E6
viral protein UBE3A targets p53 for degradation, while in the absence of E6, p53 is not a
UBE3A substrate (Scheffner, Huibregtse et al. 1993). It is possible that when bound to
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HERC2 similar conformational changes occur, altering substrate recognition leading to
the phenotypes we observed in our fly model that only emerged upon simultaneous
overexpression of both proteins. Future studies should address whether HERC2,
specifically the RLD2 domain that is known to bind UBE3A (Kuhnle, Kogel et al. 2011),
alters the structural conformation of UBE3A and changes its substrate proteins in
addition to increasing the ubiquitin ligase activity. Reducing the activity of UBE3A could
be an effective and targeted treatment for Dup15q syndrome. The identification of
individuals carrying HERC2 loss of function mutations mimicking AS suggests that
HERC2 may be necessary for the normal function of UBE3A in vivo (Puffenberger, Jinks
et al. 2012, Harlalka, Baple et al. 2013, Morice-Picard, Benard et al. 2016).
Understanding this interaction could lead to the development of Dup15q therapeutics
since compounds that disrupt the interaction between HERC2 and UBE3A may be an
effective way to reduce UBE3A activity without the requirement of dramatically
reducing UBE3A levels in Dup15q syndrome.
A Possible Role for Glia in Dup15q Epilepsy
Our fly model using glial overexpression of UBE3A is the first animal model of
Dup15q that recapitulates a clear seizure phenotype (Hope, LeDoux et al. 2017). We
constructed a unified working model based on the data presented in Chapters 4 and 5
(Figure 6-1). The tripartite synapse consists of a presynaptic neuron, a postsynaptic
neuron, and a glial cell (Perea, Navarrete et al. 2009). Upon elevation of UBE3A in glial
cells we observed reduced levels of the Na+/K+ ATPase, ATPα, and reduced levels of
intracellular K+ within glial cells. We hypothesize that this leads to a buildup of K+ in the
extracellular space because K+ is not being actively pumped into glial cells from the
synaptic space. Elevated levels of K+ surrounding neurons reduces the driving force for
positively charged K+ ions to leave the cell through K+ leak channels, resulting in a
depolarized resting membrane potential that is closer to action potential threshold
(Figure 4-10). This could result in hyperexcitable neurons, as less excitatory input is
needed to drive firing which tips networks into a hyperexcitable, seizure prone state.
Proteomic and RNAseq studies we performed revealed reduced levels of synaptic
signaling proteins predominantly located in the presynaptic compartment in a cell nonautonomous manner. The mechanism underlying the downregulation of these synaptic
proteins remains to be explored, however it is possible that reduction in synaptic proteins
is a compensatory mechanism to reduce the increased neuronal excitability caused by the
elevated levels of extracellular K+. Finally, during our analysis we found a broad
upregulation of GSTs cell autonomously within glia in response to Dube3a
overexpression that is not dependent upon elevated neuronal activity alone. This upregulation of GSTs may partially explain the pharmacoresistance of Dup15q syndrome.
In the majority of the gliopathic seizure lines identified in Chapter 5 we observed
an induction of GST gene expression. GstD1 is regulated by the transcription factor Cnc
and the repressor Keap1 in Drosophila (NRF2 and KEAP1 in humans, respectively).
Under oxidative stress conditions Cnc is relieved from Keap1 repression and binds to
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Figure 6-1. Unified working model of how elevated Dube3a in glia impacts the
tripartite synapse.
In Chapter 4 we demonstrated that elevation of Dube3a in glia causes reduced levels of
the Na+/K+ ATPase ATPα leading to a buildup of K+ in the extracellular space, and
increased extracellular K+ causes increased neuronal activity, leading to seizure-like
activity. In Chapter 5 we found a cell non-autonomous downregulation of synaptic
proteins in neurons. We also observed an upregulation of GSTs cell autonomously within
glial cells. One or more of these changes may be responsible for the seizure susceptibility
of repo>Dube3a flies.
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antioxidant response elements throughout the genome to induce oxidative stress response
genes, including GstD1 (Sykiotis and Bohmann 2008). Future experiments should
investigate whether glial cells are undergoing a generalized oxidative stress response, as
is suggested by the upregulation of GstD1, and whether this is the cause of seizures or a
secondary response.
Data presented in Chapter 5 suggests that glial cell dysfunction itself may underlie
epileptic pathologies other than Dup15q syndrome. We observed seizures in flies with
knockdown of both the α and  subunits of the Na+/K+ pump. Potassium dysregulation in
glia has been proposed as a mechanism that underlies seizure biogenesis before
(Devinsky, Vezzani et al. 2013). Additionally, glial-specific knockdown of the
mitochondrial related genes COX7A or SesB resulted in seizure phenotypes, as did glialspecific knockdown of comatose (comt), the gene encoding N-ethylmaleimide-sensitive
factor 1. Mitochondrial dysfunction has also been proposed as a cause of epilepsy
(Khurana, Valencia et al. 2013), and vesicle release machinery and exocytosis occurs in
astrocytes (reviewed in Vardjan, Parpura et al. 2016). Our findings suggest that altering
mitochondrial or vesicle function in glia results in seizure susceptibility and causes the
induction of GSTs.
In these experiments we used the pan-glial driver repo-GAL4 to drive expression
of constructs specifically within glial cells. However, Drosophila have multiple glial
subtypes within the central nervous system including astrocyte-like glia that are
functionally similar to mammalian astrocytes, cortex glia that are intimately associated
with neuronal cell bodies, and ensheathing glia that partition off portions of the fly brain
into discrete compartments (Freeman 2015). Preliminary data from our lab suggests that
elevated levels of Dube3a in astrocyte-like and cortex glia in flies contributes to the
seizure phenotype. Indeed, knockdown of the Na+/Ca2+ exchanger zydeco in Drosophila
cortex glia resulted in seizure and hyperexcitability (Melom and Littleton 2013) as did
the cation-chloride cotransporter kazachoc (Rusan, Kingsford et al. 2014). Multiple
proteins expressed within astrocyte-like glia critically regulate neuronal excitability (Cho,
Muthukumar et al. 2018). Further studies should establish the specific glial subtypes
responsible for seizure production in each gliopathic seizure line, as this may provide
insight into the mechanism of glial driven seizures.
Insights into Treatment Strategies
Data presented in Chapter 4 indicates that overexpression of Dube3a in glia prior
to the adult stage results in seizure susceptibility, however limiting overexpression of
Dube3a in glia during adulthood was not sufficient to cause seizures (Figure 4-5). These
data are consistent with findings in AS mouse models that indicate reinstating Ube3a in
neurons in adulthood does not rescue phenotypes observed in AS mice (Silva-Santos, van
Woerden et al. 2015). These data suggest some fixed change occurs in the brain during
early development caused by too little or too much UBE3A that results in long lasting
effects on behavior, including seizure susceptibility, which are not able to be rescued by
normalizing UBE3A levels. The earlier during development that a treatment strategy can
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be implemented, the better the likelihood it will be effective in controlling Dup15q
seizures.
The finding that GSTs are upregulated in several of our gliopathic seizure fly
lines is significant since upregulation of GSTs occurs in cases of idiopathic treatment
resistant epilepsy in astrocytes surrounding blood vessels and may contribute to the
treatment resistant nature of the seizures (Shang, Liu et al. 2008). GST enzymes
conjugate glutathione to small molecules facilitating their metabolism. GST upregulation
is hypothesized to underlie anti-cancer drug resistance in some instances, and may
contribute to the metabolism of AEDs (Townsend and Tew 2003, Allocati, Masulli et al.
2018). We are currently investigating whether GST upregulation occurs in the human
brain in Dup15q syndrome. If GSTs are elevated in astrocytes, as is predicted by our
Drosophila model, particularly in astrocytes surrounding blood vessels, as has been
observed in idiopathic treatment resistant epilepsies (Shang, Liu et al. 2008), then it may
be necessary to use a combination therapy approach which combines an AED with a GST
inhibitor, such as ethacrynic acid or Terrapin 199 (Tew, Dutta et al. 1997), to reduce
metabolism of the AED.
All of the experiments performed in this work were conducted in the model
organism Drosophila melanogaster. Both Drosophila Dube3a and human UBE3A
overexpression in fly glia causes a seizure phenotype, suggesting that this E3 ubiquitin
ligase can cause seizures when elevated in glia in humans as well. However, further
research needs to be conducted to determine whether glial UBE3A overexpression in
mammalian glia also causes seizures, and whether glial UBE3A overexpression
ultimately causes seizures in Dup15q syndrome. Mammalian glial cells can be broadly
broken down into three classes consisting of astrocytes, oligodendrocytes, and microglia
(Jakel and Dimou 2017). Drosophila astrocyte-like glia and cortex glia appear to be the
primary glial subtypes that underlie Drosophila gliopathic seizures, and these glia are also
the most similar in structure and function to mammalian astrocytes (Freeman 2015).
Future work will determine if overexpression of UBE3A in mouse astrocytes generates
seizures and if the molecular changes observed in our fly model of Dup15q epilepsy,
such as GST upregulation, synaptic protein downregulation, and elevated levels of
UBE3A in astrocytes occur in the Dup15q syndrome.
In summary, we demonstrated that Dube3a is not imprinted in the fly. We also
found that Dube3a and HERC2 interact synergistically to cause ASD-like phenotypes in
Drosophila that are similar to phenotypes observed in Dup15q. These data show that
Dup15q should be studied more holistically and genes located in the 15q11.2-q13.1
region other that UBE3A should not be ignored. Finally, during the course of my thesis
work we constructed the first model of Dup15q that recapitulates the seizure phenotype
of Dup15q syndrome. Our fly model suggests, for the first time, that glial cells may
underlie Dup15q seizures. Efforts are now underway to translate our findings from the fly
to mammalian systems.
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